Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
- Authors
- Strittmatter, W J; Saunders, A M; Schmechel, D; Pericak-Vance, M; Enghild, J; Salvesen, G S; Roses, A D
- Year
- 1993
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 8446617
- DOI
- 10.1073/pnas.90.5.1977
- PMCID
- PMC46003
Apolipoprotein E is immunochemically localized to the senile plaques, vascular amyloid, and neurofibrillary tangles of Alzheimer disease. In vitro, apolipoprotein E in cerebrospinal fluid binds to synthetic beta A4 peptide (the primary constituent of the senile plaque) with high avidity. Amino acids 12-28 of the beta A4 peptide are required. The gene for apolipoprotein E is located on chromosome 19q13.2, within the region previously associated with linkage of late-onset familial Alzheimer disease. Analysis of apolipoprotein E alleles in Alzheimer disease and controls demonstrated that there was a highly significant association of apolipoprotein E type 4 allele (APOE-epsilon 4) and late-onset familial Alzheimer disease. The allele frequency of the APOE-epsilon 4 in 30 random affected patients, each from a different Alzheimer disease family, was 0.50 +/- 0.06; the allele frequency of APOE-epsilon 4 in 91 age-matched unrelated controls was 0.16 +/- 0.03 (Z = 2.44, P = 0.014). A functional role of the apolipoprotein E-E4 isoform in the pathogenesis of late-onset familial Alzheimer disease is suggested.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A common 19βbp APOE enhancer deletion is protective against Alzheimer's disease in African Americans. | Brutman JN et al. | β | 2026 | β |
| Advances in hiPSC-Derived Brain Organoids as a Model to Study Neuroinflammation in Alzheimer's Disease. | Maciel EMA et al. | β | 2026 | β |
| An automated plasma-based proteotyping immunoassay for APOE Ξ΅4 zygosity classification in Alzheimer's disease. | Levin S et al. | β | 2026 | β |
| APOE4 reprograms microglial lipid metabolism in Alzheimer's disease: Mechanisms and therapeutic implications. | Chen J et al. | β | 2026 | β |
| APOE genotype differentially modulates prion pathology in a mouse model. | LiziΕczyk AM et al. | β | 2026 | β |
| APOE Ξ΅4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis. | Hatano Y et al. | β | 2026 | β |
| Apolipoprotein E Polymorphism Is Associated with Age of Onset and Neuropathology in Colony Stimulating Factor 1 Receptor-Related Disorder. | Chmiela T et al. | β | 2026 | β |
| Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance. | Huang YW et al. | β | 2026 | β |
| Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both? | Sharma A et al. | β | 2026 | β |
| Immune dysfunction in Alzheimer disease. | Butovsky O et al. | β | 2026 | β |
| Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differences based on cell type and ApoE isoform. | Strickland MR et al. | β | 2026 | β |
| Sterile innate immune mechanisms in neurodegenerative diseases. | Ealy A et al. | β | 2026 | β |
| Targeting Lipid Metabolism in Alzheimer's Disease: Emerging Insights and Future Directions. | Balakrishnan J et al. | β | 2026 | β |
| Ten-year longitudinal effects of physical activity and apolipoprotein E ..4 genotype on precuneus atrophy in Japanese older adults. | Yuki A et al. | β | 2026 | β |
| The Association between Glaucoma and Dementia in a National Cohort of All of Us Participants. | Pham K et al. | β | 2026 | β |
| The proportion of Alzheimer's disease attributable to apolipoprotein E. | Williams DM et al. | β | 2026 | β |
| A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis. | Wendt S et al. | β | 2025 | β |
| Age- and ApoE Genotype-Dependent Transcriptomic Responses to O<sub>3</sub> in the Hippocampus of Mice. | Nakamya MF et al. | β | 2025 | β |
| Alzheimer's disease and age-related macular degeneration: Shared and distinct immune mechanisms. | Butovsky O et al. | β | 2025 | β |
| A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies. | Hering H et al. | β | 2025 | β |
| A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits. | Zhou Y et al. | β | 2025 | β |
| An integrative systems-biology approach defines mechanisms of Alzheimer's disease neurodegeneration. | Leventhal MJ et al. | β | 2025 | β |
| APOE4 genotypes and the trajectory of biomarkers, neuroimaging, and cognitive measures in Alzheimer's Disease: A mixed-effects disease progression model. | Essenburg C et al. | β | 2025 | β |
| Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia. | Liampas I et al. | β | 2025 | β |
| A single fibril study reveals that ApoE inhibits the elongation of AΞ²42 fibrils in an isoform-dependent manner. | Dasadhikari S et al. | β | 2025 | β |
| Association between epigenetic mark 5-hydroxymethylcytosine and brain pathophysiology. | Kang AK et al. | β | 2025 | β |
| Association of <i>APOE</i> Ξ΅4 with cerebrospinal fluid protein and amyloid-Ξ²<sub>42</sub> levels in Alzheimer's disease. | Chen R et al. | β | 2025 | β |
| Baseline habitual dietary nitrate intake and Alzheimer's Disease related neuroimaging biomarkers in the Australian Imaging, Biomarkers and Lifestyle study of ageing. | Rajendra A et al. | β | 2025 | β |
| BEscreen: aΒ versatile toolkit to design base editing libraries. | Schneider PG et al. | β | 2025 | β |
| Bisphosphonates and the risk of dementia in patients with osteoporosis or fragility fracture: A population-based study in Hong Kong. | Sing CW et al. | β | 2025 | β |
| Border-associated macrophages: an emerging perspective from physiological basis and multi-disease roles to the mechanism of vascular cognitive impairment and dementia. | Li T et al. | β | 2025 | β |
| Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease. | Kueck PJ et al. | β | 2025 | β |
| BrainGeneBot: a framework for variant prioritization and generative pretrained transformer-informed interpretation across polygenic risk score studies. | Qu G et al. | β | 2025 | β |
| Brain volumes discriminate clinical dementia rating scale categories. | Christova P et al. | β | 2025 | β |
| Causal cardiovascular risk factors for dementia: insights from observational and genetic studies. | Kjeldsen EW et al. | β | 2025 | β |
| Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer's Disease. | Verma S et al. | β | 2025 | β |
| Context Specificity of MAP3K DLK Signaling in the Nervous System: Insights from Genetics and Genomics. | Ritchie EM et al. | β | 2025 | β |
| Deficiency of the Tangier Disease Gene Abca1 Is Associated With Microglial Defects in Mice. | Celis T et al. | β | 2025 | β |
| Deposition pattern and amino acid sequence analysis of amyloid-Ξ² in Felidae species. | Fukui H et al. | β | 2025 | β |
| Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's disease. | Campagna J et al. | β | 2025 | β |
| Disease-associated microglia in neurodegenerative diseases: Friend or foe? | Cheng YH et al. | β | 2025 | β |
| Distinct Characteristics of Suspected Non-Alzheimer Pathophysiology in Relation to Cognitive Status and Cerebrovascular Burden. | Chun MY et al. | β | 2025 | β |
| Dysregulated calcium signaling in the aged primate association cortices: vulnerability to Alzheimer's disease neuropathology. | Arnsten AFT et al. | β | 2025 | β |
| Emerging roles of astrocytes in hippocampal circuitry and behavior. | Squires A et al. | β | 2025 | β |
| Flipping APOE to reverse Alzheimer's disease traits. | Lam JYL et al. | β | 2025 | β |
| From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer's disease. | Peyvand P et al. | β | 2025 | β |
| From Skin to Brain: Key Genetic Mediators Associating Cutaneous Inflammation and Neurodegenerative Diseases. | Grech VS et al. | β | 2025 | β |
| From variants to mechanisms: Neurogenomics in the post-GWAS era. | Margolis MP et al. | β | 2025 | β |
| Fueling the brain - the role of apolipoprotein E in brain energy metabolism and its implications for Alzheimer's disease. | Budny V et al. | β | 2025 | β |
| Genetic variation in the Nr1d1 transcription factor binding site shapes metabolism-related protein networks associated with cognitive resilience in an Alzheimer's disease mouse reference panel. | Chen Y et al. | β | 2025 | β |
| History of Alzheimer's Disease Research Centers: From inception in 1984 to evolution beyond 2025. | Khachaturian Z | β | 2025 | β |
| Hormone replacement therapy and dementia risk among postmenopausal women: evidence from the UK Biobank | Squires S et al. | β | 2025 | β |
| Human herpes viruses are associated with steeper age-dependent increases of serum biomarkers for dementia in cognitively unimpaired women. | James LM et al. | β | 2025 | β |
| HYPOTHESIS: Lipid-protecting disulfide bridges are the missing molecular link between ApoE4 and sporadic Alzheimer's disease in humans. | Ramsden CE et al. | β | 2025 | β |
| Identification of diagnostic DNA methylation markers in the blood of Japanese Alzheimer's disease patients using methylation capture sequencing. | Mitsumori R et al. | β | 2025 | β |
| Integrative bioinformatics analysis of APOE variants in Alzheimer's disease and clinical therapeutics. | Srivastava K et al. | β | 2025 | β |
| Investigating shared risk variants and genetic etiology between Alzheimer's disease and three stress-related psychiatric disorders: a large-scale genome-wide cross-trait analysis. | Dang W et al. | β | 2025 | β |
| Investigation of Domain Interaction in the Apolipoprotein E Isoforms by HDX-MS. | Pal S et al. | β | 2025 | β |
| iPSC-derived neural organoids in dementia research: Recent advances and future directions. | Shima S et al. | β | 2025 | β |
| Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease. | Benussi A et al. | β | 2025 | β |
| Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications. | He S et al. | β | 2025 | β |
| Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in <i>Caenorhabditis elegans</i>. | Tortajada-PΓ©rez J et al. | β | 2025 | β |
| <i>APOE4-APP</i> interactions exert early influences on cerebrovascular structure and function: implications for Alzheimer's disease. | Guo L et al. | β | 2025 | β |
| <i>APOE</i> genotype and biological age impact inter-omic associations related to bioenergetics. | Ellis D et al. | β | 2025 | β |
| Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterols. | Nguyen C et al. | β | 2025 | β |
| Microglial mechanisms drive amyloid-Ξ² clearance in immunized patients with Alzheimer's disease. | van Olst L et al. | β | 2025 | β |
| Microglia, Trem2, and Neurodegeneration. | Shi Q et al. | β | 2025 | β |
| Mitochondrial energy production genes affecting reactive oxygen species and ATP synthesis, inflammatory pathways, and neuron viability are differentially expressed in brains of Alzheimer's disease patients. | Pflanzer H et al. | β | 2025 | β |
| Modeling Alzheimer's Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling. | Timofeeva AM et al. | β | 2025 | β |
| Molecular Biomarkers Associated with Traumatic Brain Injury Outcome in Individuals of Black Racial Identity or African Ancestry: A Narrative Review. | Wroblewski TH et al. | β | 2025 | β |
| Neuronal ABCA7 deficiency aggravates mitochondrial dysfunction and neurodegeneration in Alzheimer's disease. | Wang N et al. | β | 2025 | β |
| Potential multiple disease progression pathways in female patients with Alzheimer's disease inferred from transcriptome and epigenome data of the dorsolateral prefrontal cortex. | Honda K et al. | β | 2025 | β |
| Proteostasis disruption and lipid dyshomeostasis in neurodegeneration: exploring common druggable targets across sporadic and monogenic disorders. | Pereira Sena P et al. | β | 2025 | β |
| Role of Oxidative Stress and Neuroinflammation in the Etiology of Alzheimer's Disease: Therapeutic Options. | Weinstock M | β | 2025 | β |
| Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E Ξ΅4. | Kim SG et al. | β | 2025 | β |
| Sex-specific brain atrophy patterns associated with the motoric cognitive risk syndrome. | Blumen HM et al. | β | 2025 | β |
| Sex variation in the relationship between <i>APOE</i> Ξ΅4, cognitive decline, and dementia. | Kerr EM et al. | β | 2025 | β |
| Shorter Telomere Length in Individuals with Neurocognitive Disorder and <i>APOE</i> Ξ΅4 Genotype. | MejΓa-Ortiz P et al. | β | 2025 | β |
| Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics-Part A: Endogenous Compounds and Repurposed Drugs. | Atanasova M | β | 2025 | β |
| Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics-Part B: Natural Compounds. | Atanasova M | β | 2025 | β |
| Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis. | Jiang WI et al. | β | 2025 | β |
| The association of human apolipoprotein Ξ΅4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo. | Ikanga J et al. | β | 2025 | β |
| The connection between autophagy and Alzheimer's disease. | Lior N et al. | β | 2025 | β |
| The continued promise of genomic technologies and software in neurogenetics. | Xu IRL et al. | β | 2025 | β |
| The effect of C-reactive protein and interleukin-3 on mild cognitive impairment with <i>APOE</i> Ι4. | Yang X et al. | β | 2025 | β |
| The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances. | Andersen JV | β | 2025 | β |
| The HDL-Mimetic Peptide 4F Mitigates Vascular and Cortical Amyloid Pathology and Associated Neuroinflammation in a Transgenic Mouse Model of Cerebral Amyloid Angiopathy and Alzheimer's Disease. | Zhong R et al. | β | 2025 | β |
| The history of Down syndrome-associated Alzheimer's disease; past, present, and future. | Maure-Blesa L et al. | β | 2025 | β |
| The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress. | Cacabelos R et al. | β | 2025 | β |
| The relationship between neuropsychiatric dimensions and markers of Parkinson's disease risk in the UK Biobank. | Attaallah B et al. | β | 2025 | β |
| The Spectrum of Genetic Risk in Alzheimer Disease. | Karagas N et al. | β | 2025 | β |
| Transcription Factor-Wide Association Studies to Identify Functional SNPs in Alzheimer's Disease. | Dunn J et al. | β | 2025 | β |
| Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets. | Chauhan P et al. | β | 2025 | β |
| Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications. | Wang Y et al. | β | 2025 | β |
| Visualization of Apolipoprotein E-Binding Amyloid Plaques in Postmortem Alzheimer's Disease Brains Using a Novel Fluorescent Probe THK-5320. | Harada R et al. | β | 2025 | β |
| AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer's disease mice. | GΓΌnaydin C et al. | β | 2024 | β |
| A case for seeking sex-specific treatments in Alzheimer's disease. | Lynch MA | β | 2024 | β |
| A circadian clock regulates the blood-brain barrier across phylogeny. | Avila A et al. | β | 2024 | β |
| Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. | Kloske CM et al. | β | 2024 | β |
| A hybrid constrained continuous optimization approach for optimal causal discovery from biological data. | Zhu Y et al. | β | 2024 | β |
| Altered glia-neuron communication in Alzheimer's Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq. | Soelter TM et al. | β | 2024 | β |
| Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges. | Safiri S et al. | β | 2024 | β |
| Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. | Carling GK et al. | β | 2024 | β |
| Alzheimer's disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity. | PaveΕ‘koviΔ M et al. | β | 2024 | β |
| APOE from astrocytes restores Alzheimer's AΞ²-pathology and DAM-like responses in APOE deficient microglia. | Preman P et al. | β | 2024 | β |
| ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9. | Ghosh S et al. | β | 2024 | β |
| ApoE: The Non-Protagonist Actor in Neurological Diseases. | Grimaldi L et al. | β | 2024 | β |
| APOEΞ΅4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial. | Zeng Y et al. | β | 2024 | β |
| Apolipoprotein E and Alzheimer's Disease in Italian Population: Systematic Review and Meta-Analysis. | Abrego-Guandique DM et al. | β | 2024 | β |
| Apolipoproteine and <i>KLOTHO</i> Gene Variants Do Not Affect the Penetrance of Fragile X-Associated Tremor/Ataxia Syndrome. | Winarni TI et al. | β | 2024 | β |
| Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice. | Ritchie M et al. | β | 2024 | β |
| Assessing interstitial fluid dynamics in type 2 diabetes mellitus and prediabetes cases through diffusion tensor imaging analysis along the perivascular space. | Tuerxun R et al. | β | 2024 | β |
| Assessing the Impact and Cost-Effectiveness of Exposome Interventions on Alzheimer's Disease: A Review of Agent-Based Modeling and Other Data Science Methods for Causal Inference. | Liu SH et al. | β | 2024 | β |
| Association between oral health and cognitive impairment in older adults: Insights from a Six-year prospective cohort study. | Chen JT et al. | β | 2024 | β |
| Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders. | Hasnain N et al. | β | 2024 | β |
| Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence. | Amidfar M et al. | β | 2024 | β |
| Association of TMEM106B with Cortical <i>APOE</i> Gene Expression in Neurodegenerative Conditions. | Picard C et al. | β | 2024 | β |
| Astrocytes: The Stars in Neurodegeneration? | Stoklund Dittlau K et al. | β | 2024 | β |
| A systematic review of the role of TREM2 in Alzheimer's disease. | Yin Y et al. | β | 2024 | β |
| Cholesterol Metabolism in Neurodegenerative Diseases. | He K et al. | β | 2024 | β |
| COVID-19 outcomes among patients with dementia and age-matched controls who were hospitalized in 21 US health-care systems. | Johnson AL et al. | β | 2024 | β |
| Cryo-EM structures of amyloid-Ξ² and tau filaments in Down syndrome. | Fernandez A et al. | β | 2024 | β |
| Cryo-EM structures of cotton wool plaques' amyloid Ξ² and of tau filaments in dominantly inherited Alzheimer disease. | Hoq MR et al. | β | 2024 | β |
| Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives. | Bhole RP et al. | β | 2024 | β |
| Defining a vitamin A5/X specific deficiency - vitamin A5/X as a critical dietary factor for mental health. | BΓ‘nΓ‘ti D et al. | β | 2024 | β |
| Diabetes mellitus and risk of incident dementia in APOE Ι4 carriers: an updated meta-analysis. | Rashtchian A et al. | β | 2024 | β |
| Diagnosis of Alzheimer's disease: Towards accuracy and accessibility. | Mu Y et al. | β | 2024 | β |
| DNA methylation of imprint control regions associated with Alzheimer's disease in non-Hispanic Blacks and non-Hispanic Whites. | Cevik SE et al. | β | 2024 | β |
| Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now? | Sequeira L et al. | β | 2024 | β |
| Editorial: Meeting new challenges in translationally relevant neurodegenerative disease research. | Latimer CS et al. | β | 2024 | β |
| Epigenetic dysregulation in Alzheimer's disease peripheral immunity. | Ramakrishnan A et al. | β | 2024 | β |
| Ethical issues in genomics research in persons with Alzheimer's Disease/Alzheimer's Disease-related dementia (AD/ADRD): a systematic review. | Yakubu A et al. | β | 2024 | β |
| Explainable deep neural networks for predicting sample phenotypes from single-cell transcriptomics. | Martorell-MarugΓ‘n J et al. | β | 2024 | β |
| Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) study. | Nguyen CQN et al. | β | 2024 | β |
| Frontiers and hotspots evolution between air pollution and Alzheimer's disease: A bibliometric analysis from 2013 to 2023. | Liu Z et al. | β | 2024 | β |
| Fueling Alzheimer's Disease: Where Does Immunometabolism Stand? | Correia SC et al. | β | 2024 | β |
| Genetic Risk for Alzheimer's Disease Alters Perceived Executive Dysfunction in Cognitively Healthy Middle-Aged and Older Adults. | Evans SA et al. | β | 2024 | β |
| Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use. | Sayfullaeva J et al. | β | 2024 | β |
| Human apolipoprotein E glycosylation and sialylation: from structure to function. | Moon HJ et al. | β | 2024 | β |
| Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies. | Pappolla MA et al. | β | 2024 | β |
| Inflammasome signaling is dispensable for Γ-amyloid-induced neuropathology in preclinical models of Alzheimer's disease. | Srinivasan S et al. | β | 2024 | β |
| Insights into the roles of Apolipoprotein E in adipocyte biology and obesity. | Jiang CL et al. | β | 2024 | β |
| Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022. | Kong F et al. | β | 2024 | β |
| Lessons from genetic studies in Alzheimer disease. | Nicolas G | β | 2024 | β |
| Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment. | NyΓΊl-TΓ³th Γ et al. | β | 2024 | β |
| Lipid Droplets and Neurodegeneration. | Mallick K et al. | β | 2024 | β |
| Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia. | Juul Rasmussen I et al. | β | 2024 | β |
| Lipophorin receptors genetically modulate neurodegeneration caused by reduction of Psn expression in the aging Drosophila brain. | Kang J et al. | β | 2024 | β |
| Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer's Disease. | Petralla S et al. | β | 2024 | β |
| Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis. | Schmidt AF et al. | β | 2024 | β |
| <i>APOE3</i> Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease. | Quiroz YT et al. | β | 2024 | β |
| Machine learning quantification of Amyloid-Ξ² deposits in the temporal lobe of 131 brain bank cases. | Scalco R et al. | β | 2024 | β |
| Olfactory Dysfunction and Alzheimer's Disease: A Review. | McLaren AMR et al. | β | 2024 | β |
| Physical Exercise Counteracts Aging-Associated White Matter Demyelination Causing Cognitive Decline. | Butt TH et al. | β | 2024 | β |
| Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease. | Walker L et al. | β | 2024 | β |
| Recent advances in Alzheimer disease genetics. | Nicolas G | β | 2024 | β |
| Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease. | Vance JM et al. | β | 2024 | β |
| Schizophrenia genomics: genetic complexity and functional insights. | Sullivan PF et al. | β | 2024 | β |
| Sex and Gender Differences in Alzheimer's Disease: Genetic, Hormonal, and Inflammation Impacts. | Kolahchi Z et al. | β | 2024 | β |
| Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults. | Rajan KB et al. | β | 2024 | β |
| Strategies for measuring concentrations and forms of amyloid-Ξ² peptides. | Shen H et al. | β | 2024 | β |
| Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-Ξ² Precursor Protein in Alzheimer's Disease. | Khan MA | β | 2024 | β |
| The advent of Alzheimer treatments will change the trajectory of human aging. | Selkoe DJ | β | 2024 | β |
| The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed. | Tavares-JΓΊnior JWL et al. | β | 2024 | β |
| The effects of APOEe4 allele on cerebral structure, function, and related interactions with cognition in young adults. | Kucikova L et al. | β | 2024 | β |
| The influence of APOE<sup>Ξ΅4</sup> on the pTau interactome in sporadic Alzheimer's disease. | Thierry M et al. | β | 2024 | β |
| The mTOR Pathway: A Common Link Between Alzheimer's Disease and Down Syndrome. | Wohlfert AJ et al. | β | 2024 | β |
| Therapeutic agents for Alzheimer's disease: a critical appraisal. | Weinstock M | β | 2024 | β |
| The study on cuproptosis in Alzheimer's disease based on the cuproptosis key gene <i>FDX1</i>. | Chen G et al. | β | 2024 | β |
| Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis. | Area-Gomez E et al. | β | 2024 | β |
| Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline. | Wybitul M et al. | β | 2024 | β |
| Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches. | Firdaus Z et al. | β | 2024 | β |
| Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias. | Cooper O et al. | β | 2024 | β |
| Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia. | Greenblatt CL et al. | β | 2024 | β |
| Zexieyin formula alleviates atherosclerosis with cognitive impairment: A novel role in the treatment of comorbidities and its underlying mechanisms. | Sun Y et al. | β | 2024 | β |
| 3D genome-selected microRNAs to improve Alzheimer's disease prediction. | Li K et al. | β | 2023 | β |
| A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer's Disease. | Huang X | β | 2023 | β |
| Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. | Harned TC et al. | β | 2023 | β |
| AD and non-AD mediators of the pathway between the APOE genotype and cognition. | Nichols E et al. | β | 2023 | β |
| Advanced photon counting CT imaging pipeline for cardiac phenotyping of apolipoprotein E mouse models. | Allphin AJ et al. | β | 2023 | β |
| Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases. | Li L et al. | β | 2023 | β |
| Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease. | Li Y et al. | β | 2023 | β |
| A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease. | Bai H et al. | β | 2023 | β |
| Altered DNA methylome profiles of blood leukocytes in Chinese patients with mild cognitive impairment and Alzheimer's disease. | Wu S et al. | β | 2023 | β |
| Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression. | Meftah S et al. | β | 2023 | β |
| Alzheimer's disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs. | Arizaca Maquera KA et al. | β | 2023 | β |
| A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity. | Anderson G | β | 2023 | β |
| Anchoring of Amyloid-Ξ² onto Polyunsaturated Phospholipid Membranes. | Yuan R et al. | β | 2023 | β |
| APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFΞ²-mediated checkpoints. | Yin Z et al. | β | 2023 | β |
| APOE and immunity: Research highlights. | Kloske CM et al. | β | 2023 | β |
| ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer's disease. | Ramsden CE et al. | β | 2023 | β |
| Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms. | Stuchell-Brereton MD et al. | β | 2023 | β |
| Apolipoprotein E in lipid metabolism and neurodegenerative disease. | Yang LG et al. | β | 2023 | β |
| A Review on Phyto-Therapeutic Approaches in Alzheimer's Disease. | Sahiner M et al. | β | 2023 | β |
| Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. | Brandebura AN et al. | β | 2023 | β |
| Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy. | Xiong M et al. | β | 2023 | β |
| Bayesian nonparametric method for genetic dissection of brain activation region. | Jin Z et al. | β | 2023 | β |
| Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology. | Gouilly D et al. | β | 2023 | β |
| Bibliometric analysis of global research on the role of apolipoprotein E in Alzheimer's disease. | Wang Z et al. | β | 2023 | β |
| Bidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles. | Zhou W et al. | β | 2023 | β |
| Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease. | Franco GA et al. | β | 2023 | β |
| CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice. | Greco GA et al. | β | 2023 | β |
| Discovery of a Missense Mutation (Q222K) of the <i>APOE</i> Gene from the Australian Imaging, Biomarker and Lifestyle Study. | Roberts BR et al. | β | 2023 | β |
| Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease. | Tamburini B et al. | β | 2023 | β |
| Enrichr-KG: bridging enrichment analysis across multiple libraries. | Evangelista JE et al. | β | 2023 | β |
| Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration. | Lathe R et al. | β | 2023 | β |
| Evolution and Predictive Role of Plasma Alzheimer's Disease-related Pathological Biomarkers in Parkinson's Disease. | Lin J et al. | β | 2023 | β |
| Examining the Lancet Commission risk factors for dementia using Mendelian randomisation. | Desai R et al. | β | 2023 | β |
| Excitatory Neurons Derived from Human-Induced Pluripotent Stem Cells Show Transcriptomic Differences in Alzheimer's Patients from Controls. | Sagar R et al. | β | 2023 | β |
| Exploration of acupuncture therapy in the treatment of MCI patients with the ApoE Ξ΅4 gene based on the brain-gut axis theory. | Jin Y et al. | β | 2023 | β |
| Extracellular chaperone networks and the export of J-domain proteins. | Braun JEA | β | 2023 | β |
| Extracranial carotid artery atherosclerotic plaque and APOE polymorphisms: a systematic review and meta-analysis. | Culleton S et al. | β | 2023 | β |
| Fundamental Neurochemistry Review: Microglial immunometabolism in traumatic brain injury. | Strogulski NR et al. | β | 2023 | β |
| Genetic Phenotypes of Alzheimer's Disease: Mechanisms and Potential Therapy. | Quan M et al. | β | 2023 | β |
| How Can Insulin Resistance Cause Alzheimer's Disease? | Yoon JH et al. | β | 2023 | β |
| Hypothesis review: Alzheimer's overture guidelines. | Ferrer I | β | 2023 | β |
| <i>APOE</i> genotype and sex modulate Alzheimer's disease pathology in aged EFAD transgenic mice. | Balu D et al. | β | 2023 | β |
| <i>APOE</i> genotypes modify the obesity paradox in dementia. | Shinohara M et al. | β | 2023 | β |
| Identification of high-performing antibodies for Apolipoprotein E for use in Western Blot and immunoprecipitation. | Ayoubi R et al. | β | 2023 | β |
| Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective. | Rajah Kumaran K et al. | β | 2023 | β |
| In Silico Design of Natural Inhibitors of ApoE4 from the Plant <i>Moringa oleifera</i>: Molecular Docking and Ab Initio Fragment Molecular Orbital Calculations. | Shaji D et al. | β | 2023 | β |
| Interactive association of posttraumatic stress disorder, apolipoprotein Ξ΅4 genotype, and age on cognitive functioning. | Lawrence KA et al. | β | 2023 | β |
| Investigation of the Relationship between Apolipoprotein E Alleles and Serum Lipids in Alzheimer's Disease: A Meta-Analysis. | Xu H et al. | β | 2023 | β |
| Lack of ApoE inhibits ADan amyloidosis in a mouse model of familial Danish dementia. | Fernandez A et al. | β | 2023 | β |
| LilrB3 is a putative cell surface receptor of APOE4. | Zhou J et al. | β | 2023 | β |
| Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men. | GarcΓa-GonzΓ‘lez P et al. | β | 2023 | β |
| Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission - The essential roles of astrocytes. | Andersen JV et al. | β | 2023 | β |
| Molecular modeling of apoE in complexes with Alzheimer's amyloid-Ξ² fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids. | Lewkowicz E et al. | β | 2023 | β |
| Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans. | Garcia Manriquez BA et al. | β | 2023 | β |
| Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets. | Zhang L et al. | β | 2023 | β |
| Novel Functional Genomics Approaches Bridging Neuroscience and Psychiatry. | Restrepo-Lozano JM et al. | β | 2023 | β |
| Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer's disease pathogenesis in the brain during peripheral chronic inflammation. | Na H et al. | β | 2023 | β |
| Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer's disease: Ab initio molecular simulations. | Shaji D et al. | β | 2023 | β |
| Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPΞ² levels in cerebrospinal fluid and 2D/3D cell culture models. | Wittrahm R et al. | β | 2023 | β |
| Ranking the risk factors for Alzheimer's disease; findings from the UK Biobank study. | Allwright M et al. | β | 2023 | β |
| Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease. | Su M et al. | β | 2023 | β |
| Reelin through the years: From brain development to inflammation. | Alexander A et al. | β | 2023 | β |
| Sister haplotypes and recombination disequilibrium: a new approach to identify associations of haplotypes with complex diseases. | Liao SY et al. | β | 2023 | β |
| Spinal apolipoprotein E is involved in inflammatory pain via regulating lipid metabolism and glial activation in the spinal dorsal horn. | Liu S et al. | β | 2023 | β |
| Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease. | Lambert JC et al. | β | 2023 | β |
| Targeting apolipoprotein E and N-terminal amyloid Ξ²-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer's mice. | Sawmiller D et al. | β | 2023 | β |
| The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview. | Swerdlow RH | β | 2023 | β |
| The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells. | Cai W et al. | β | 2023 | β |
| The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. | Nelson MR et al. | β | 2023 | β |
| The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases? | Bustos LM et al. | β | 2023 | β |
| The Impact of Apolipoprotein E (<i>APOE</i>) Epigenetics on Aging and Sporadic Alzheimer's Disease. | Lozupone M et al. | β | 2023 | β |
| The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration. | Masi M et al. | β | 2023 | β |
| The neurobiology and therapeutic potential of multi-targeting Ξ²-secretase, glycogen synthase kinase 3Ξ² and acetylcholinesterase in Alzheimer's disease. | Fronza MG et al. | β | 2023 | β |
| The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action. | Vuu YM et al. | β | 2023 | β |
| The role of opioid receptors in modulating Alzheimer's Disease. | Tanguturi P et al. | β | 2023 | β |
| The unique neuropathological vulnerability of the human brain to aging. | I F | β | 2023 | β |
| TNFΞ± Activates the Liver X Receptor Signaling Pathway and Promotes Cholesterol Efflux from Human Brain Pericytes Independently of <i>ABCA1</i>. | Dib S et al. | β | 2023 | β |
| TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease. | La Rosa F et al. | β | 2023 | β |
| Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment. | Higginbotham L et al. | β | 2023 | β |
| Adenosine receptor signalling in Alzheimer's disease. | Trinh PNH et al. | β | 2022 | β |
| Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes leading to cognitive impairment. | Zhang M et al. | β | 2022 | β |
| Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease. | Thrush KL et al. | β | 2022 | β |
| Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective. | Ferrer I | β | 2022 | β |
| Amyloid Ξ², Tau, and Ξ±-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. | Sengupta U et al. | β | 2022 | β |
| Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease. | Laffoon SB et al. | β | 2022 | β |
| Animal and Cellular Models of Alzheimer's Disease: Progress, Promise, and Future Approaches. | Trujillo-Estrada L et al. | β | 2022 | β |
| APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. | Blanchard JW et al. | β | 2022 | β |
| ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. | Raulin AC et al. | β | 2022 | β |
| APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease. | Parhizkar S et al. | β | 2022 | β |
| Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma. | Margeta MA et al. | β | 2022 | β |
| Apolipoprotein E and Alzheimer's disease. | Troutwine BR et al. | β | 2022 | β |
| Apolipoprotein E Genotype e2: Neuroprotection and Its Limits. | Kim H et al. | β | 2022 | β |
| Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? | Vecchio FL et al. | β | 2022 | β |
| Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers. | Bridel C et al. | β | 2022 | β |
| Association Between Antibiotic Treatment of Leptospirosis Infections and Reduced Risk of Dementia: A Nationwide, Cohort Study in Taiwan. | Chao PC et al. | β | 2022 | β |
| Association of <i>APOE</i>-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults. | Xicota L et al. | β | 2022 | β |
| Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China. | Jiao B et al. | β | 2022 | β |
| Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: Integration of the glutamate/GABA-glutamine cycle. | Andersen JV et al. | β | 2022 | β |
| Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. | Saroja SR et al. | β | 2022 | β |
| Brain integrity is altered by hepatic APOE Ξ΅4 in humanized-liver mice. | Giannisis A et al. | β | 2022 | β |
| Building in vitro models of the brain to understand the role of <i>APOE</i> in Alzheimer's disease. | Pinals RL et al. | β | 2022 | β |
| Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old. | Lachner C et al. | β | 2022 | β |
| Central nervous system cholesterol metabolism in health and disease. | Ho WY et al. | β | 2022 | β |
| Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome. | Abbasi DA et al. | β | 2022 | β |
| Chronic Ethanol Causes Persistent Increases in Alzheimer's Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment. | Tucker AE et al. | β | 2022 | β |
| Common human genetic variants of APOE impact murine COVID-19 mortality. | Ostendorf BN et al. | β | 2022 | β |
| Current landscape of gene-editing technology in biomedicine: Applications, advantages, challenges, and perspectives. | Zhou W et al. | β | 2022 | β |
| Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease. | Cummings J et al. | β | 2022 | β |
| Dissecting the clinical heterogeneity of early-onset Alzheimer's disease. | Sirkis DW et al. | β | 2022 | β |
| Endogenous Human Proteins Interfering with Amyloid Formation. | Gharibyan AL et al. | β | 2022 | β |
| Enhanced activity of Alzheimer disease-associated variant of protein kinase CΞ± drives cognitive decline in a mouse model. | LordΓ©n G et al. | β | 2022 | β |
| Erythrocyte sphingolipid species as biomarkers of Alzheimer's disease. | Mill J et al. | β | 2022 | β |
| Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer's Disease. | Minocha T et al. | β | 2022 | β |
| Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function. | Rueter J et al. | β | 2022 | β |
| Genetics of Alzheimer Disease. | Jayadev S | β | 2022 | β |
| Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation. | Sharafeldin N et al. | β | 2022 | β |
| <i>APOE</i> Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population. | Papastefanopoulou V et al. | β | 2022 | β |
| Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges. | Han J et al. | β | 2022 | β |
| Inverse Association of APOE Ξ΅4 and Glaucoma Modified by Systemic Hypertension: The Canadian Longitudinal Study on Aging. | Freeman EE et al. | β | 2022 | β |
| <i>Perilla</i> seed oil in combination with nobiletin-rich ponkan powder enhances cognitive function in healthy elderly Japanese individuals: a possible supplement for brain health in the elderly. | Hashimoto M et al. | β | 2022 | β |
| Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers. | Duong MT et al. | β | 2022 | β |
| Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans. | Ramsden CE et al. | β | 2022 | β |
| Lipoproteins in the Central Nervous System: From Biology to Pathobiology. | Raulin AC et al. | β | 2022 | β |
| Longitudinal Analysis of the Retina and Choroid in Cognitively Normal Individuals at Higher Genetic Risk of Alzheimer Disease. | Ma JP et al. | β | 2022 | β |
| Mechanistic Link between Vitamin B12 and Alzheimer's Disease. | Lauer AA et al. | β | 2022 | β |
| Modulation of retinoid-X-receptors differentially regulates expression of apolipoprotein genes apoc1 and apoeb by zebrafish microglia. | Thiel WA et al. | β | 2022 | β |
| Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease. | Gan Q et al. | β | 2022 | β |
| Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family. | Tejada Moreno JA et al. | β | 2022 | β |
| Network dysfunction in cognitively normal APOE Ξ΅4 carriers is related to subclinical tau. | Butt OH et al. | β | 2022 | β |
| Neuroimmune contributions to Alzheimer's disease: a focus on human data. | Haage V et al. | β | 2022 | β |
| Neuroprotective Effects of Vapreotide on Tau Transfection-Induced Neurodegeneration. | UzunhisarcΔ±klΔ± E et al. | β | 2022 | β |
| Novel molecular mechanisms in Alzheimer's disease: The potential role of DEK in disease pathogenesis. | Greene AN et al. | β | 2022 | β |
| Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders. | Azari A et al. | β | 2022 | β |
| Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. | Pedrini S et al. | β | 2022 | β |
| Polygenic hazard score modified the relationship between hippocampal subfield atrophy and episodic memory in older adults. | Xu J et al. | β | 2022 | β |
| Potential role of dietary nitrate in relation to cardiovascular and cerebrovascular health, cognition, cognitive decline and dementia: a review. | Rajendra A et al. | β | 2022 | β |
| Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis. | Islam S et al. | β | 2022 | β |
| Selective reduction of astrocyte apoE3 and apoE4 strongly reduces AΞ² accumulation and plaque-related pathology in a mouse model of amyloidosis. | Mahan TE et al. | β | 2022 | β |
| Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Microglia from APOE Targeted Replacement Mice. | Mhatre-Winters I et al. | β | 2022 | β |
| Sex and gender differences in dementia. | Salwierz P et al. | β | 2022 | β |
| SNP-by-CpG Site Interactions in <i>ABCA7</i> Are Associated with Cognition in Older African Americans. | Chaar DL et al. | β | 2022 | β |
| Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic AΞ² Peptides. | Hanbouch L et al. | β | 2022 | β |
| Structural Determinant of Ξ²-Amyloid Formation: From Transmembrane Protein Dimerization to Ξ²-Amyloid Aggregates. | Papadopoulos N et al. | β | 2022 | β |
| Structure-Property-Activity Relationships in Carbon Dots. | Zhou Y et al. | β | 2022 | β |
| The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models. | Anand C et al. | β | 2022 | β |
| The impact of genetic risk for Alzheimer's disease on the structural brain networks of young adults. | Mirza-Davies A et al. | β | 2022 | β |
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. | Frisoni GB et al. | β | 2022 | β |
| Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspective. | Ahmed S et al. | β | 2022 | β |
| The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease. | Bossaerts L et al. | β | 2022 | β |
| The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives. | Rosmus DD et al. | β | 2022 | β |
| The synapse as a treatment avenue for Alzheimer's Disease. | Peng L et al. | β | 2022 | β |
| Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations. | Motazedi E et al. | β | 2022 | β |
| Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics. | Horimoto ARVR et al. | β | 2021 | β |
| A goodness-of-fit test based on neural network sieve estimators. | Shen X et al. | β | 2021 | β |
| A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages. | Park JY et al. | β | 2021 | β |
| An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease. | Vidal C et al. | β | 2021 | β |
| Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model. | Litvinchuk A et al. | β | 2021 | β |
| Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-Ξ². | Chai AB et al. | β | 2021 | β |
| Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-ΞΊB-Mediated Production of CXCL1. | Kemp SB et al. | β | 2021 | β |
| Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. | Chen Y et al. | β | 2021 | β |
| A prospective cohort study of prodromal Alzheimer's disease: Prospective Imaging Study of Ageing: Genes, Brain and Behaviour (PISA). | Lupton MK et al. | β | 2021 | β |
| A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease. | Cioffi F et al. | β | 2021 | β |
| ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISMS AND EPILEPSY IN CHILDREN. | KukuruzoviΔ M et al. | β | 2021 | β |
| Association between Sleep, Alzheimer's, and Parkinson's Disease. | Matsumoto S et al. | β | 2021 | β |
| Association of Apolipoprotein E Ι4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. | Bejanin A et al. | β | 2021 | β |
| Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection. | Hilser JR et al. | β | 2021 | β |
| A Structured Brain-wide and Genome-wide Association Study Using ADNI PET Images. | Li Y et al. | β | 2021 | β |
| Bibliometric analysis of the top 100 most cited studies in apolipoprotein E (ApoE) research. | Ahmad T et al. | β | 2021 | β |
| Brain Organoids: Studying Human Brain Development and Diseases in a Dish. | Xu J et al. | β | 2021 | β |
| Brain Somatic Mutation in Aging and Alzheimer's Disease. | Miller MB et al. | β | 2021 | β |
| Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects. | Feringa FM et al. | β | 2021 | β |
| Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy. | Duong MT et al. | β | 2021 | β |
| Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment? | LordΓ©n G et al. | β | 2021 | β |
| Data analysis with Shapley values for automatic subject selection in Alzheimer's disease data sets using interpretable machine learning. | Bloch L et al. | β | 2021 | β |
| Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease. | Hu Y et al. | β | 2021 | β |
| Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice. | den Hoedt S et al. | β | 2021 | β |
| Evaluation of <i>APOE</i> Ι2/Ι3/Ι4 Alleles in a Cohort of Individuals Affected by Developmental Topographical Disorientation. | Barclay SF et al. | β | 2021 | β |
| Exosomal AΞ²-Binding Proteins Identified by "In Silico" Analysis Represent Putative Blood-Derived Biomarker Candidates for AlzheimerΒ΄s Disease. | Soares Martins T et al. | β | 2021 | β |
| Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology. | Rahman MM et al. | β | 2021 | β |
| From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy. | Cheng YJ et al. | β | 2021 | β |
| Genetic Insights into Alzheimer's Disease. | Latimer CS et al. | β | 2021 | β |
| Glycosaminoglycans in Neurodegenerative Diseases. | Jin W et al. | β | 2021 | β |
| High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease. | Pedrini S et al. | β | 2021 | β |
| <i>APOE</i> <i>Ι</i>4 Allele and Financial Capacity Performance in Mild Alzheimer's Disease: A Pilot Study. | Giannouli V et al. | β | 2021 | β |
| Identification of Cathepsin D as a Plasma Biomarker for Alzheimer's Disease. | Kim JW et al. | β | 2021 | β |
| Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community-based cohort study. | Fani L et al. | β | 2021 | β |
| Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous <i>APOE</i> Ι4 Carriers. | Tao Q et al. | β | 2021 | β |
| Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners? | Ahmed MM et al. | β | 2021 | β |
| Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants. | Hoogmartens J et al. | β | 2021 | β |
| Interplay Between Microglia and Alzheimer's Disease-Focus on the Most Relevant Risks: APOE Genotype, Sex and Age. | Chen Y et al. | β | 2021 | β |
| Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery. | Yeh SJ et al. | β | 2021 | β |
| In vitro neuroprotective effects of farnesene sesquiterpene on alzheimer's disease model of differentiated neuroblastoma cell line. | Arslan ME et al. | β | 2021 | β |
| Late-in-life neurodegeneration after chronic sleep loss in young adult mice. | Owen JE et al. | β | 2021 | β |
| Lipid droplets in the nervous system. | Ralhan I et al. | β | 2021 | β |
| Metabolic disorder in Alzheimer's disease. | Poddar MK et al. | β | 2021 | β |
| Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models. | Trombetta-Lima M et al. | β | 2021 | β |
| Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease? | Zhang Z et al. | β | 2021 | β |
| Multiomics integrative analysis identifies <i>APOE</i> allele-specific blood biomarkers associated to Alzheimer's disease etiopathogenesis. | Madrid L et al. | β | 2021 | β |
| Nerve Growth Factor Compromise in Down Syndrome. | Do Carmo S et al. | β | 2021 | β |
| Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players. | Pfrieger FW | β | 2021 | β |
| Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer's disease-associated genes. | Moulton MJ et al. | β | 2021 | β |
| Obstructive Sleep Apnea and Cognitive Decline: A Review of Potential Vulnerability and Protective Factors. | Legault J et al. | β | 2021 | β |
| Origins, Biology, and Diseases of Tissue Macrophages. | Cox N et al. | β | 2021 | β |
| Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE Ι3/Ι4 Carriers. | Edlund AK et al. | β | 2021 | β |
| Protective genes and pathways in Alzheimer's disease: moving towards precision interventions. | Seto M et al. | β | 2021 | β |
| Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. | Bai B et al. | β | 2021 | β |
| Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models. | Gurdon B et al. | β | 2021 | β |
| Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. | Wang H et al. | β | 2021 | β |
| Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. | Cooper JM et al. | β | 2021 | β |
| Relationship Between Genetic Variants of ACAT1 and APOE with the Susceptibility to Dementia (SADEM Study). | Alavez-Rubio JS et al. | β | 2021 | β |
| Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease. | Whitwell JL et al. | β | 2021 | β |
| Research on the Glial-Lymphatic System and Its Relationship With Alzheimer's Disease. | Ding D et al. | β | 2021 | β |
| Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. | Wang C et al. | β | 2021 | β |
| Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits. | Tierney E et al. | β | 2021 | β |
| Synaptic tau: A pathological or physiological phenomenon? | Robbins M et al. | β | 2021 | β |
| Synthesis, Computational Pharmacokinetics Report, Conceptual DFT-Based Calculations and Anti-Acetylcholinesterase Activity of Hydroxyapatite Nanoparticles Derived From <i>Acorus Calamus</i> Plant Extract. | Pradeep S et al. | β | 2021 | β |
| Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation. | Willems S et al. | β | 2021 | β |
| The Association of Essential Metals with APOE Genotype in Alzheimer's Disease. | BabiΔ Leko M et al. | β | 2021 | β |
| The effects of antimony on Alzheimer's disease-like pathological changes in mice brain. | Xu S et al. | β | 2021 | β |
| The heterogeneity among subgroups of haplogroup J influencing Alzheimer's disease risk. | Liu H et al. | β | 2021 | β |
| The Interplay of ABC Transporters in AΞ² Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease. | Behl T et al. | β | 2021 | β |
| The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review. | Beardmore R et al. | β | 2021 | β |
| The Potential Utility of Prebiotics to Modulate Alzheimer's Disease: A Review of the Evidence. | Kang JW et al. | β | 2021 | β |
| Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD. | Sabbagh MN et al. | β | 2021 | β |
| TM2D genes regulate Notch signaling and neuronal function in Drosophila. | Salazar JL et al. | β | 2021 | β |
| Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEΞ΅4 and Trem2*R47H. | Kotredes KP et al. | β | 2021 | β |
| When the time is right: Temporal dynamics of brain activity in healthy aging and dementia. | Courtney SM et al. | β | 2021 | β |
| A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy. | Taylor X et al. | β | 2020 | β |
| Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. | Saddiki H et al. | β | 2020 | β |
| Age-dependent effect of APOE and polygenic component on Alzheimer's disease. | Bellou E et al. | β | 2020 | β |
| Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction. | Sutovsky S et al. | β | 2020 | β |
| Alzheimer's Disease and Herbal Combination Therapy: A Comprehensive Review. | Pradeep S et al. | β | 2020 | β |
| Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? | Mullane K et al. | β | 2020 | β |
| Alzheimer's Disease: What Can We Learn From the Peripheral Olfactory System? | Dibattista M et al. | β | 2020 | β |
| An update on human astrocytes and their role in development and disease. | de Majo M et al. | β | 2020 | β |
| APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. | Li Z et al. | β | 2020 | β |
| APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review. | Emrani S et al. | β | 2020 | β |
| APOE4 moderates effects of cortical iron on synchronized default mode network activity in cognitively healthy old-aged adults. | Kagerer SM et al. | β | 2020 | β |
| APOE-amyloid interaction: Therapeutic targets. | Wisniewski T et al. | β | 2020 | β |
| ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease. | Lanfranco MF et al. | β | 2020 | β |
| Apolipoprotein E impairs amyloid-Ξ² fibril elongation and maturation. | Islam T et al. | β | 2020 | β |
| Apolipoprotein E polymorphism carriers exhibit objective cognitive deficits: a single center trial. | Zeng Y et al. | β | 2020 | β |
| Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis. | McComb M et al. | β | 2020 | β |
| A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic AΞ² Clearance. | Zhang H et al. | β | 2020 | β |
| A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer's Disease and Frontotemporal Dementia Disease Modeling. | MuΓ±oz SS et al. | β | 2020 | β |
| Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry. | Blue EE et al. | β | 2020 | β |
| Astrocyte senescence promotes glutamate toxicity in cortical neurons. | Limbad C et al. | β | 2020 | β |
| A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases. | Soyal SM et al. | β | 2020 | β |
| Autophagy in Astrocytes and its Implications in Neurodegeneration. | Sung K et al. | β | 2020 | β |
| Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration. | FernΓ‘ndez-Cabello S et al. | β | 2020 | β |
| Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories. | Butterfield DA | β | 2020 | β |
| Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice. | Kaya I et al. | β | 2020 | β |
| Cerebellar Volume Is Associated with Cognitive Decline in Mild Cognitive Impairment: Results from ADNI. | Lin CY et al. | β | 2020 | β |
| Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. | Greenberg SM et al. | β | 2020 | β |
| Characterization of a G-Quadruplex Structure in Pre-miRNA-1229 and in Its Alzheimer's Disease-Associated Variant rs2291418: Implications for miRNA-1229 Maturation. | Imperatore JA et al. | β | 2020 | β |
| "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics. | Yang HJ et al. | β | 2020 | β |
| Clusterin as a Potential Biomarker of Obesity-Related Alzheimer's Disease Risk. | Bradley D | β | 2020 | β |
| Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-Ξ² plaques. | Hashimoto T et al. | β | 2020 | β |
| Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk. | Dzianok P et al. | β | 2020 | β |
| Common germline variants of the human APOE gene modulate melanoma progression and survival. | Ostendorf BN et al. | β | 2020 | β |
| Consideration of Sex Differences in the Measurement and Interpretation of Alzheimer Disease-Related Biofluid-Based Biomarkers. | Mielke MM | β | 2020 | β |
| Dementia risk in women higher in same-sex than opposite-sex twins. | Luo J et al. | β | 2020 | β |
| Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans. | Green EH et al. | β | 2020 | β |
| Diabetes Mellitus Increases Risk of Incident Dementia in APOEΙ4 Carriers: A Meta-Analysis. | Li L et al. | β | 2020 | β |
| Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment andΒ early mild cognitive impairment. | Cho H et al. | β | 2020 | β |
| Effects of an APOE Promoter Polymorphism on Fronto-Parietal Functional Connectivity During Nondemented Aging. | Zhang Q et al. | β | 2020 | β |
| Finnish neuroscience from past to present. | Korpi ER et al. | β | 2020 | β |
| Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local Ξ²-amyloid, Tau, and APOE4. | Quevenco FC et al. | β | 2020 | β |
| Genetic architecture of neurodegenerative dementias. | Clarimon J et al. | β | 2020 | β |
| Genetic Burden for Late-Life Neurodegenerative Disease and Its Association With Early-Life Lipids, Brain, Behavior, and Cognition. | Lamballais S et al. | β | 2020 | β |
| Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults. | Prieto S et al. | β | 2020 | β |
| Higher risk of dementia in English older individuals who are overweight or obese. | Ma Y et al. | β | 2020 | β |
| HIV-1 Tat: Role in Bystander Toxicity. | Ajasin D et al. | β | 2020 | β |
| If Human Brain Organoids Are the Answer to Understanding Dementia, What Are the Questions? | Ooi L et al. | β | 2020 | β |
| Immune response and endocytosis pathways are associated with the resilience against Alzheimer's disease. | Tesi N et al. | β | 2020 | β |
| In search of multimodal brain alterations in Alzheimer's and Binswanger's disease. | Fu Z et al. | β | 2020 | β |
| Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease. | Kulas JA et al. | β | 2020 | β |
| Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease. | PerdigΓ£o C et al. | β | 2020 | β |
| Invited Review: The role of prion-like mechanisms in neurodegenerative diseases. | Jaunmuktane Z et al. | β | 2020 | β |
| Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary. | Percy ME et al. | β | 2020 | β |
| Leveraging preclinical models for the development of Alzheimer disease therapeutics. | Scearce-Levie K et al. | β | 2020 | β |
| Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease. | Schmitz TW et al. | β | 2020 | β |
| MCC-SP: a powerful integration method for identification of causal pathways from genetic variants to complex disease. | Zhu Y et al. | β | 2020 | β |
| Microglia and Astrocytes in Disease: Dynamic Duo or Partners in Crime? | Liddelow SA et al. | β | 2020 | β |
| Microglia in Alzheimer's Disease in the Context of Tau Pathology. | Perea JR et al. | β | 2020 | β |
| Microglia, Lifestyle Stress, and Neurodegeneration. | Madore C et al. | β | 2020 | β |
| Molecular Insight into the Therapeutic Promise of Targeting <i>APOE4</i> for Alzheimer's Disease. | Mamun AA et al. | β | 2020 | β |
| Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer's Disease. | Kaeser GE et al. | β | 2020 | β |
| MRI-based biomarkers of accelerated aging and dementia risk in midlife: how close are we? | Elliott ML | β | 2020 | β |
| Pathway-Specific Genetic Risk for Alzheimer's Disease Differentiates Regional Patterns of Cortical Atrophy in Older Adults. | Caspers S et al. | β | 2020 | β |
| PICALM Rescues Endocytic Defects Caused by the Alzheimer's Disease Risk Factor APOE4. | Narayan P et al. | β | 2020 | β |
| Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions. | Baker E et al. | β | 2020 | β |
| Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype. | Motta C et al. | β | 2020 | β |
| Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration. | PΓ©rez M et al. | β | 2020 | β |
| Pulsed SILAM Reveals In Vivo Dynamics of Murine Brain Protein Translation. | Ng SS et al. | β | 2020 | β |
| Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases. | Minta K et al. | β | 2020 | β |
| Rationale for the development of an Alzheimer's disease vaccine. | Kwan P et al. | β | 2020 | β |
| Sex-dependent effect of <i>APOE</i> on Alzheimer's disease and other age-related neurodegenerative disorders. | Gamache J et al. | β | 2020 | β |
| Shifting paradigms: The central role of microglia in Alzheimer's disease. | Schwabe T et al. | β | 2020 | β |
| Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid. | Hu Y et al. | β | 2020 | β |
| Tau at the interface between neurodegeneration and neuroinflammation. | Didonna A | β | 2020 | β |
| The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship. | Li QS et al. | β | 2020 | β |
| [The future of dementia prevention and treatment strategies]. | β | β | 2020 | β |
| The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse. | Sohn JH et al. | β | 2020 | β |
| The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer's Disease. | Kloske CM et al. | β | 2020 | β |
| The multiplex model of the genetics of Alzheimer's disease. | Sims R et al. | β | 2020 | β |
| Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease. | Williams T et al. | β | 2020 | β |
| The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease. | Chernick D et al. | β | 2020 | β |
| The Role of Sex and Sex Hormones in Neurodegenerative Diseases. | Vegeto E et al. | β | 2020 | β |
| Upregulation of Alzheimer's Disease Amyloid-Ξ² Protein Precursor in Astrocytes Both in vitro and in vivo. | Liang Y et al. | β | 2020 | β |
| Vascular Homeostasis and Inflammation in Health and Disease-Lessons from Single Cell Technologies. | Bondareva O et al. | β | 2020 | β |
| Aberrant memory system connectivity and working memory performance in subjective cognitive decline. | Viviano RP et al. | β | 2019 | β |
| A Biophysical Approach to the Identification of Novel ApoE Chemical Probes. | Kraft L et al. | β | 2019 | β |
| ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease. | Alavez-Rubio JS et al. | β | 2019 | β |
| Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-Ξ΅4-associated Alzheimer's disease. | Delikkaya B et al. | β | 2019 | β |
| Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer's Disease. | MartΓnez de Toda I et al. | β | 2019 | β |
| Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. | Long JM et al. | β | 2019 | β |
| Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric AΞ² and Tau Species. | Chen XQ et al. | β | 2019 | β |
| Alzheimer's disease. | Soria Lopez JA et al. | β | 2019 | β |
| Amyloid-Ξ² and Tau at theΒ Crossroads of Alzheimer's Disease. | Gallardo G et al. | β | 2019 | β |
| An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease. | Menta BW et al. | β | 2019 | β |
| ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease. | Jeong W et al. | β | 2019 | β |
| ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-Ξ² copathology. | Koriath C et al. | β | 2019 | β |
| ApoE-fragment/AΞ² heteromers in the brain of patients with Alzheimer's disease. | Mouchard A et al. | β | 2019 | β |
| APOE Ξ΅4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop. | Murray CE et al. | β | 2019 | β |
| Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond. | Fuior EV et al. | β | 2019 | β |
| Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease. | Karim R et al. | β | 2019 | β |
| Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response. | Johnson LA et al. | β | 2019 | β |
| Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. | Hubin E et al. | β | 2019 | β |
| Apolipoprotein E DNA methylation and posttraumatic stress disorder are associated with plasma ApoE level: A preliminary study. | Nielsen DA et al. | β | 2019 | β |
| Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample. | Rajan KB et al. | β | 2019 | β |
| Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. | Marais AD | β | 2019 | β |
| Apolipoprotein E-Ξ΅4 allele predicts escalation of psychotic symptoms in late adulthood. | Jonas K et al. | β | 2019 | β |
| A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward. | Belloy ME et al. | β | 2019 | β |
| A short perspective on the long road to effective treatments for Alzheimer's disease. | Reynolds DS | β | 2019 | β |
| Association analysis of polymorphisms in <i>STARD6</i> and near <i>ECHDC3</i> in Alzheimer's disease patients carrying the <i>APOE</i> Ξ΅4 Allele. | Yin J et al. | β | 2019 | β |
| Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis. | Abyadeh M et al. | β | 2019 | β |
| Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort. | Guven G et al. | β | 2019 | β |
| Benefits and Challenges of Rare Genetic Variation in Alzheimer's Disease. | Grozeva D et al. | β | 2019 | β |
| BMI-associated gene variants in <i>FTO</i> and cardiometabolic and brain disease: obesity or pleiotropy? | Ganeff IMM et al. | β | 2019 | β |
| Body Shape and Alzheimer's Disease: A Mendelian Randomization Analysis. | Zhou Y et al. | β | 2019 | β |
| Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals? | George EK et al. | β | 2019 | β |
| CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease. | Huang F et al. | β | 2019 | β |
| Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer's disease. | Tesi N et al. | β | 2019 | β |
| Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment. | Park JE et al. | β | 2019 | β |
| Childhood trauma interacts with ApoE to influence neurocognitive function in women living with HIV. | Womersley JS et al. | β | 2019 | β |
| Cognitive resilience among APOE Ξ΅4 carriers in the oldest old. | Hayden KM et al. | β | 2019 | β |
| Current Updates on the Regulation of Beta-Secretase Movement as a Potential Restorative Focus for Management of Alzheimer's Disease. | Ahmad SS et al. | β | 2019 | β |
| Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. | Savelieff MG et al. | β | 2019 | β |
| Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk. | Huang YA et al. | β | 2019 | β |
| Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. | Bussy A et al. | β | 2019 | β |
| Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena. | Ji Y et al. | β | 2019 | β |
| Elevated Membrane Cholesterol Disrupts Lysosomal Degradation to Induce Ξ²-Amyloid Accumulation: The Potential Mechanism Underlying Augmentation of Ξ²-Amyloid Pathology by Type 2 Diabetes Mellitus. | Takeuchi S et al. | β | 2019 | β |
| Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease. | Fetahu IS et al. | β | 2019 | β |
| Estrogen activates Alzheimer's disease genes. | Ratnakumar A et al. | β | 2019 | β |
| Evaluation of <i>APOE</i> Genotype and Vascular Risk Factors As Prognostic and Risk Factors for Alzheimer's Disease and Their Influence On Age of Symptoms Onset. | Novotni G et al. | β | 2019 | β |
| Exosome Production Is Key to Neuronal Endosomal Pathway Integrity in Neurodegenerative Diseases. | Mathews PM et al. | β | 2019 | β |
| Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease. | Cuello AC et al. | β | 2019 | β |
| Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations. | Fragoza R et al. | β | 2019 | β |
| Functional MRI of brain physiology in aging and neurodegenerative diseases. | Chen JJ | β | 2019 | β |
| Gain and loss events in the evolution of the apolipoprotein family in vertebrata. | Liu JQ et al. | β | 2019 | β |
| Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease. | Baker E et al. | β | 2019 | β |
| Genetic Markers of Alzheimer's Disease. | Nikolac Perkovic M et al. | β | 2019 | β |
| Genetic Study of Alzheimer's Disease in Saudi Population. | El Bitar F et al. | β | 2019 | β |
| Hidden Aggregation Hot-Spots on Human Apolipoprotein E: A Structural Study. | Tsiolaki PL et al. | β | 2019 | β |
| Higher Level of Mismatch in APOEΞ΅4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid. | Vogelgsang J et al. | β | 2019 | β |
| History and progress of hypotheses and clinical trials for Alzheimer's disease. | Liu PP et al. | β | 2019 | β |
| Homomeric and Heteromeric AΞ² Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype. | Lana E et al. | β | 2019 | β |
| <i>APOE</i> Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of <i>APOE</i> Ξ΅4 on Alzheimer's Disease Risk in a Multiracial Sample. | Choi KY et al. | β | 2019 | β |
| Immune Signaling in Neurodegeneration. | Hammond TR et al. | β | 2019 | β |
| Increased cerebral blood volume in small arterial vessels is aΒ correlate of amyloid-Ξ²-related cognitive decline. | Hua J et al. | β | 2019 | β |
| Knowledge domain and emerging trends in Alzheimer's disease: a scientometric review based on CiteSpace analysis. | Liu S et al. | β | 2019 | β |
| Lipid Assemblies at the Crossroads of Aging, Proteostasis, and Neurodegeneration. | Roitenberg N et al. | β | 2019 | β |
| Low Evolutionary Selection Pressure in Senescence Does Not Explain the Persistence of AΞ² in the Vertebrate Genome. | Moir RD et al. | β | 2019 | β |
| Modeling Alzheimer's disease with human iPS cells: advancements, lessons, and applications. | Essayan-Perez S et al. | β | 2019 | β |
| Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease. | Cioffi F et al. | β | 2019 | β |
| Multitasking: Dual Leucine Zipper-Bearing Kinases in Neuronal Development and Stress Management. | Jin Y et al. | β | 2019 | β |
| Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. | Wadhwani AR et al. | β | 2019 | β |
| Non-coding variability at the APOE locus contributes to the Alzheimer's risk. | Zhou X et al. | β | 2019 | β |
| Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease. | Liyanage SI et al. | β | 2019 | β |
| Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice. | de Retana SF et al. | β | 2019 | β |
| Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier. | Chernick D et al. | β | 2019 | β |
| Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia <i>in vitro</i>. | Muth C et al. | β | 2019 | β |
| Race, APOEΙ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample. | Rajan KB et al. | β | 2019 | β |
| Relationship between Basal Forebrain Resting-State Functional Connectivity and Brain Amyloid-Ξ² Deposition in Cognitively Intact Older Adults with Subjective Memory Complaints. | Chiesa PA et al. | β | 2019 | β |
| Role of TREM2 in Alzheimer's Disease and its Consequences on Ξ²- Amyloid, Tau and Neurofibrillary Tangles. | Singh AK et al. | β | 2019 | β |
| Sex differences in Alzheimer's disease: Understanding the molecular impact. | Toro CA et al. | β | 2019 | β |
| Synaptic Elimination in Neurological Disorders. | Cardozo PL et al. | β | 2019 | β |
| Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight. | Ebbert MTW et al. | β | 2019 | β |
| Systematic Identification of Cell-Cell Communication Networks in the Developing Brain. | Sheikh BN et al. | β | 2019 | β |
| Targeting apolipoprotein E for treating Alzheimer's disease. | Bales KR et al. | β | 2019 | β |
| Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy. | Chornenkyy Y et al. | β | 2019 | β |
| The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation. | Castellani RJ et al. | β | 2019 | β |
| The Ankle-Brachial Index Is Associated with Cerebral Ξ²-Amyloid Deposition in Cognitively Normal Older Adults. | Moon SW et al. | β | 2019 | β |
| The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded AΞ² and prion proteins. | Rossi M et al. | β | 2019 | β |
| The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer's Disease. | Fernandez CG et al. | β | 2019 | β |
| TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE Ι3 Homozygotes. | Watts A et al. | β | 2019 | β |
| Understanding the Amyloid Hypothesis in Alzheimer's Disease. | Paroni G et al. | β | 2019 | β |
| Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects. | Kumar S et al. | β | 2018 | β |
| A High-fat and High-Cholesterol Diet Potentiates Oxidative Damage in Hippocampus of Mice Lacking Apolipoprotein E. | Guaraldi M et al. | β | 2018 | β |
| Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. | Martins RN et al. | β | 2018 | β |
| Amyloid toxicity in Alzheimer's disease. | Reiss AB et al. | β | 2018 | β |
| APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types. | Lin YT et al. | β | 2018 | β |
| APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review. | Forero DA et al. | β | 2018 | β |
| Association of Apolipoprotein E Ξ΅4 With Transactive Response DNA-Binding Protein 43. | Wennberg AM et al. | β | 2018 | β |
| Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers. | Tao Q et al. | β | 2018 | β |
| Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review. | Ruthirakuhan M et al. | β | 2018 | β |
| Blood will out: vascular contributions to Alzheimer's disease. | Strickland S | β | 2018 | β |
| Brain Under Stress and Alzheimer's Disease. | Mravec B et al. | β | 2018 | β |
| Cellular Receptors of Amyloid Ξ² Oligomers (AΞ²Os) in Alzheimer's Disease. | Mroczko B et al. | β | 2018 | β |
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. | Lewczuk P et al. | β | 2018 | β |
| Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease. | Chen JJ | β | 2018 | β |
| Chasing the signaling run by tri-molecular time-lapse FRET microscopy. | Kuo HL et al. | β | 2018 | β |
| Classification and Prediction of Brain Disorders Using Functional Connectivity: Promising but Challenging. | Du Y et al. | β | 2018 | β |
| Cloning and spatiotemporal expression of Xenopus laevis Apolipoprotein CI. | Sridharan J et al. | β | 2018 | β |
| Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain. | Thangavel R et al. | β | 2018 | β |
| Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds. | Prinzi G et al. | β | 2018 | β |
| Composition of Exfoliation Material. | Challa P et al. | β | 2018 | β |
| Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review). | Hassan M et al. | β | 2018 | β |
| Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design. | Sehgal SA et al. | β | 2018 | β |
| Development of a new biochip array for APOE4 classification from plasma samples using immunoassay-based methods. | Badrnya S et al. | β | 2018 | β |
| Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. | Deczkowska A et al. | β | 2018 | β |
| Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research? | Fan Y et al. | β | 2018 | β |
| Effects of <i>APOE</i> Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease. | Dai J et al. | β | 2018 | β |
| Enhanced capillary electrophoretic screening of Alzheimer based on direct apolipoprotein E genotyping and one-step multiplex PCR. | Woo N et al. | β | 2018 | β |
| Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer's Disease. | Miranda AM et al. | β | 2018 | β |
| Extracting Complementary Insights from Molecular Phenotypes for Prioritization of Disease-Associated Mutations. | Wierbowski SD et al. | β | 2018 | β |
| Functional brain network centrality is related to APOE genotype in cognitively normal elderly. | Wink AM et al. | β | 2018 | β |
| Genetic Modifiers in Neurodegeneration. | Jain N et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Genomics: New Light on Alzheimer's Disease Research. | Jung YJ et al. | β | 2018 | β |
| GJA1 (connexin43) is a key regulator of Alzheimer's disease pathogenesis. | Kajiwara Y et al. | β | 2018 | β |
| Harnessing neuroplasticity: modern approaches and clinical future. | Sasmita AO et al. | β | 2018 | β |
| High-density lipoprotein mimetic peptide 4F mitigates amyloid-Ξ²-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia. | Chernick D et al. | β | 2018 | β |
| Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production. | Guimas Almeida C et al. | β | 2018 | β |
| Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review. | Benedict C et al. | β | 2018 | β |
| Insulin Resistance in Alzheimer's Disease. | Ferreira LSS et al. | β | 2018 | β |
| Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-Ξ² accumulation in Alzheimer's disease. | Yamaguchi-Kabata Y et al. | β | 2018 | β |
| Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study. | Van Hooren RWE et al. | β | 2018 | β |
| Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. | Shi Y et al. | β | 2018 | β |
| In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits. | Tangwongchai S et al. | β | 2018 | β |
| Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE Ξ΅4 genotype. | Mishra S et al. | β | 2018 | β |
| <i>APOE</i> Ξ΅4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. | Dickson DW et al. | β | 2018 | β |
| Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans. | Weissberger GH et al. | β | 2018 | β |
| Microglia in Alzheimer's disease. | Hansen DV et al. | β | 2018 | β |
| Modelling Alzheimer's disease: Insights from in vivo to in vitro three-dimensional culture platforms. | Ranjan VD et al. | β | 2018 | β |
| Nano- and neurotoxicology: An emerging discipline. | Bencsik A et al. | β | 2018 | β |
| Neuropsychological Predictors of Long-Term (10 Years) Mild Cognitive Impairment Stability. | Alves L et al. | β | 2018 | β |
| Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches. | Kumar NN et al. | β | 2018 | β |
| Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases. | Teijido O et al. | β | 2018 | β |
| Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases. | Tao YX et al. | β | 2018 | β |
| Physical activity is associated with higher cognitive function among adults at risk for Alzheimer's disease. | Frith E et al. | β | 2018 | β |
| Polymorphism and plasma levels of apolipoprotein E and the risk of aneurysmal subarachnoid hemorrhage in a Chinese population: a case-control study. | Liu X et al. | β | 2018 | β |
| Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer's Disease. | Ce O et al. | β | 2018 | β |
| Pyk2 is a Novel Tau Tyrosine Kinase thatΒ isΒ Regulated by the Tyrosine Kinase Fyn. | Li C et al. | β | 2018 | β |
| Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies. | Gupta N et al. | β | 2018 | β |
| Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. | Blautzik J et al. | β | 2018 | β |
| Selenium, selenoprotein P, and Alzheimer's disease: is there a link? | Solovyev N et al. | β | 2018 | β |
| Sex differences in the association between apolipoprotein E Ξ΅4 allele and Alzheimer's disease markers. | Sundermann EE et al. | β | 2018 | β |
| SMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment. | Stoffel W et al. | β | 2018 | β |
| Spatiotemporal Propagation of the Cortical Atrophy: Population and Individual Patterns. | Koval I et al. | β | 2018 | β |
| Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials. | Castrillo JI et al. | β | 2018 | β |
| Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. | Liao F et al. | β | 2018 | β |
| Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid deposition. | Borchelt DR | β | 2018 | β |
| Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold. | Falcon B et al. | β | 2018 | β |
| The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions. | Orme T et al. | β | 2018 | β |
| The Glymphatic System in Diabetes-Induced Dementia. | Kim YK et al. | β | 2018 | β |
| The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease. | Kokiko-Cochran ON et al. | β | 2018 | β |
| The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia. | Tasaki S et al. | β | 2018 | β |
| The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders. | Willsey AJ et al. | β | 2018 | β |
| Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, Ξ±-synuclein, amyloid-Ξ² and insulin resistance in neurodegenerative diseases. | Clark IA et al. | β | 2018 | β |
| The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives. | Wolfe CM et al. | β | 2018 | β |
| The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review. | Freudenberg-Hua Y et al. | β | 2018 | β |
| The Synergistic Effects of APOE Genotype and Obesity on Alzheimer's Disease Risk. | Jones NS et al. | β | 2018 | β |
| TREM2 - a key player in microglial biology and Alzheimer disease. | Ulland TK et al. | β | 2018 | β |
| TREM2-Dependent Effects on Microglia in Alzheimer's Disease. | Zhou Y et al. | β | 2018 | β |
| Untangling Genetic Risk for Alzheimer's Disease. | Pimenova AA et al. | β | 2018 | β |
| Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration. | Rao SS et al. | β | 2018 | β |
| Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease. | Larsen PA et al. | β | 2018 | β |
| Zebrafish: an emerging real-time model system to study Alzheimer's disease and neurospecific drug discovery. | Saleem S et al. | β | 2018 | β |
| Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of Ξ²-amyloidosis. | Huynh TV et al. | β | 2017 | β |
| A Longitudinal Item Response Theory Model to Characterize Cognition Over Time in Elderly Subjects. | Vandemeulebroecke M et al. | β | 2017 | β |
| Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene. | Traversy MT et al. | β | 2017 | β |
| Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. | Song W et al. | β | 2017 | β |
| Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons. | Harasta AE et al. | β | 2017 | β |
| Alzheimer's Disease: Past, Present, and Future. | Bondi MW et al. | β | 2017 | β |
| Amyloid beta: structure, biology and structure-based therapeutic development. | Chen GF et al. | β | 2017 | β |
| An Alzheimers disease related genes identification method based on multiple classifier integration. | Miao Y et al. | β | 2017 | β |
| A New Decision Tree to Solve the Puzzle of Alzheimer's Disease Pathogenesis Through Standard Diagnosis Scoring System. | Kumar A et al. | β | 2017 | β |
| ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and AΞ² Secretion. | Huang YA et al. | β | 2017 | β |
| ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. | Shi Y et al. | β | 2017 | β |
| APOE Ξ΅4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults. | Taylor WD et al. | β | 2017 | β |
| Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-Ξ² and other amyloidogenic proteins. | Huynh TV et al. | β | 2017 | β |
| Apolipoprotein E variants and genetic susceptibility to combat-related post-traumatic stress disorder: a meta-analysis. | Roby Y | β | 2017 | β |
| APP Function and Lipids: A Bidirectional Link. | Grimm MO et al. | β | 2017 | β |
| Applications of Resting-State Functional Connectivity to Neurodegenerative Disease. | Zhou J et al. | β | 2017 | β |
| Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients. | Zhang Y et al. | β | 2017 | β |
| Astrocyte lipid metabolism is critical for synapse development and function in vivo. | van Deijk AF et al. | β | 2017 | β |
| Astrocytes in a dish: Using pluripotent stem cells to model neurodegenerative and neurodevelopmental disorders. | Crompton LA et al. | β | 2017 | β |
| Biomarkers in Neurodegenerative Diseases. | Jeromin A et al. | β | 2017 | β |
| Cellular cholesterol homeostasis and Alzheimer's disease. | Chang TY et al. | β | 2017 | β |
| Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum. | Cervera-Carles L et al. | β | 2017 | β |
| Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity. | Pate KM et al. | β | 2017 | β |
| Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral Ξ²-amyloidosis. | FernΓ‘ndez-de-Retana S et al. | β | 2017 | β |
| Clearance of cerebral AΞ² in Alzheimer's disease: reassessing the role of microglia and monocytes. | Zuroff L et al. | β | 2017 | β |
| Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins. | Avila J et al. | β | 2017 | β |
| Cognitive genomics: Searching for the genetic roots of neuropsychological functioning. | Bearden CE et al. | β | 2017 | β |
| Cognitive impairment in progressive supranuclear palsy is associated with tau burden. | Koga S et al. | β | 2017 | β |
| Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births. | Bhaumik P et al. | β | 2017 | β |
| Conserved regulators of cognitive aging: From worms to humans. | Arey RN et al. | β | 2017 | β |
| Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease. | Saul A et al. | β | 2017 | β |
| Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. | Geifman N et al. | β | 2017 | β |
| Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function. | Cukier HN et al. | β | 2017 | β |
| Gene Linkage and Systems Biology. | Cookson MR | β | 2017 | β |
| Genetic Aspects of Susceptibility to Mercury Toxicity: An Overview. | Andreoli V et al. | β | 2017 | β |
| Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature. | Fagan ES et al. | β | 2017 | β |
| Genetics of neurodegenerative diseases: an overview. | PihlstrΓΈm L et al. | β | 2017 | β |
| Genetics of psychosis of Alzheimer disease. | Shah C et al. | β | 2017 | β |
| Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study. | Bressler J et al. | β | 2017 | β |
| Genome-wide network-based pathway analysis of CSF t-tau/AΞ²1-42 ratio in the ADNI cohort. | Cong W et al. | β | 2017 | β |
| Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment. | Lacour A et al. | β | 2017 | β |
| Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene. | Sun GZ et al. | β | 2017 | β |
| <i>APOE</i>*<i>E4</i> Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline. | Haller S et al. | β | 2017 | β |
| Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer's Disease. | Urfer-Buchwalder A et al. | β | 2017 | β |
| Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance. | TautvydaitΔ D et al. | β | 2017 | β |
| Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-Ξ² (AΞ²) Toxicity in Yeast. | Chen X et al. | β | 2017 | β |
| Intrinsic functional connectivity alterations in cognitively intact elderly APOE Ξ΅4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study. | Luo X et al. | β | 2017 | β |
| Is Sleep Disruption a Risk Factor for Alzheimer's Disease? | Macedo AC et al. | β | 2017 | β |
| Is sporadic Alzheimer's disease a developmental disorder? | Arendt T et al. | β | 2017 | β |
| Ligands of Therapeutic Utility for the Liver X Receptors. | Komati R et al. | β | 2017 | β |
| Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease. | Zakaria R et al. | β | 2017 | β |
| M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory. | Volmar CH et al. | β | 2017 | β |
| Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study. | Bressler J et al. | β | 2017 | β |
| Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology? | Taga M et al. | β | 2017 | β |
| Mitochondria, Cybrids, Aging, and Alzheimer's Disease. | Swerdlow RH et al. | β | 2017 | β |
| Modeling Gene-Environment Interactions With Quasi-Natural Experiments. | Schmitz L et al. | β | 2017 | β |
| Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease. | Jeong S | β | 2017 | β |
| Monoaminergic neuropathology in Alzheimer's disease. | Ε imiΔ G et al. | β | 2017 | β |
| Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease. | Mano T et al. | β | 2017 | β |
| Neuroprotective Actions of Dietary Choline. | Blusztajn JK et al. | β | 2017 | β |
| Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access. | McInerney MP et al. | β | 2017 | β |
| Obesity Accelerates Alzheimer-Related Pathology in <i>APOE4</i> but not <i>APOE3</i> Mice. | Moser VA et al. | β | 2017 | β |
| Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice. | Mellott TJ et al. | β | 2017 | β |
| PKR involvement in Alzheimer's disease. | Hugon J et al. | β | 2017 | β |
| Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels. | den Hoedt S et al. | β | 2017 | β |
| Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia. | Teijido Γ et al. | β | 2017 | β |
| Potential Neuroprotective Effects of Adiponectin in Alzheimer's Disease. | Ng RC et al. | β | 2017 | β |
| Practical considerations for choosing a mouse model of Alzheimer's disease. | Jankowsky JL et al. | β | 2017 | β |
| Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease. | Macdonald IR et al. | β | 2017 | β |
| Recent omics technologies and their emerging applications for personalised medicine. | Kim DH et al. | β | 2017 | β |
| Role of BACE1 in Alzheimer's synaptic function. | Das B et al. | β | 2017 | β |
| Role of Glutamate and NMDA Receptors in Alzheimer's Disease. | Wang R et al. | β | 2017 | β |
| [Search for risk genes in Alzheimer's disease]. | Karaca I et al. | β | 2017 | β |
| Seeds of Destruction: New Mechanistic Insights into the Role of Apolipoprotein E4 in Alzheimer's Disease. | Vassar R | β | 2017 | β |
| Sex and the development of Alzheimer's disease. | Pike CJ | β | 2017 | β |
| Sleep quality and duration in relation to memory in the elderly: Initial results from the Hellenic Longitudinal Investigation of Aging and Diet. | Tsapanou A et al. | β | 2017 | β |
| Somatostatin binds to the human amyloid Ξ² peptide and favors the formation of distinct oligomers. | Wang H et al. | β | 2017 | β |
| The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway. | Jendresen C et al. | β | 2017 | β |
| The apolipoprotein E gene affects the three-year trajectories of compensatory neural processes in the left-lateralized hippocampal network. | Ye Q et al. | β | 2017 | β |
| The Birth of the Modern Era of Parkinson's Disease Genetics. | Singleton AB et al. | β | 2017 | β |
| The most popular genes in the human genome. | Dolgin E | β | 2017 | β |
| The pleiotropic vasoprotective functions of high density lipoproteins (HDL). | Boyce G et al. | β | 2017 | β |
| The role of the immune system in Alzheimer disease: Etiology and treatment. | Jevtic S et al. | β | 2017 | β |
| Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before: ApoE, APP transcription and AD: Hypothesised mechanisms and existing knowledge gaps. | Lee LC et al. | β | 2017 | β |
| TREM2, Microglia, and Neurodegenerative Diseases. | Yeh FL et al. | β | 2017 | β |
| ABCA7 frameshift deletion associated with Alzheimer disease in African Americans. | Cukier HN et al. | β | 2016 | β |
| Actin dynamics and cofilin-actin rods in alzheimer disease. | Bamburg JR et al. | β | 2016 | β |
| Alteration of mitochondrial phospholipid due to the PLA<sub>2</sub> activation in rat brains under cadmium toxicity. | Sivaprakasam C et al. | β | 2016 | β |
| Alzheimer's as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks. | Castrillo JI et al. | β | 2016 | β |
| Alzheimer's Disease Genetic Risk Factor APOE-Ξ΅4 Also Affects Normal Brain Function. | Di Battista AM et al. | β | 2016 | β |
| Alzheimer's disease: presence and role of microRNAs. | Basavaraju M et al. | β | 2016 | β |
| A MULTIVARIATE FINITE MIXTURE LATENT TRAJECTORY MODEL WITH APPLICATION TO DEMENTIA STUDIES. | Lai D et al. | β | 2016 | β |
| Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease. | Qiu WQ et al. | β | 2016 | β |
| Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores. | Arbor SC et al. | β | 2016 | β |
| Amyloid Ξ²-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets. | Han SH et al. | β | 2016 | β |
| Amyloid-Ξ² peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAΞ²ACs. | Kumar R et al. | β | 2016 | β |
| An Overview of Genome-Wide Association Studies in Alzheimer's Disease. | Shen L et al. | β | 2016 | β |
| ApoE4 upregulates the activity of mitochondria-associated ER membranes. | Tambini MD et al. | β | 2016 | β |
| Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging. | Kwon OD | β | 2016 | β |
| Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples. | Gillespie AK et al. | β | 2016 | β |
| Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence. | Yamazaki Y et al. | β | 2016 | β |
| Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer's Disease. | Lista S et al. | β | 2016 | β |
| A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism. | Zhong L et al. | β | 2016 | β |
| Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease. | Osborn LM et al. | β | 2016 | β |
| Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease. | Ibarria M et al. | β | 2016 | β |
| Bioactive Compound Screen for Pharmacological Enhancers of Apolipoprotein E in Primary Human Astrocytes. | Finan GM et al. | β | 2016 | β |
| Butyrylcholinesterase K and Apolipoprotein E-Ι4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects. | De Beaumont L et al. | β | 2016 | β |
| Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis. | Mun MJ et al. | β | 2016 | β |
| Canonical and Non-canonical Reelin Signaling. | Bock HH et al. | β | 2016 | β |
| Cerebrospinal fluid-induced retardation of amyloid Ξ² aggregation correlates with Alzheimer's disease and the APOE Ξ΅4 allele. | Padayachee ER et al. | β | 2016 | β |
| Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein Ξ΅4 on memory decline in older adults. | Sundermann EE et al. | β | 2016 | β |
| Cognitive Impairment and Progression of CKD. | Kurella Tamura M et al. | β | 2016 | β |
| Current and novel therapeutic molecules and targets in Alzheimer's disease. | Kumar A et al. | β | 2016 | β |
| Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE Ι4 Carriers: A Preliminary Study. | Luo X et al. | β | 2016 | β |
| Defining the Genetic Architecture of Alzheimer's Disease: Where Next. | Sims R et al. | β | 2016 | β |
| Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know? | Herbert J et al. | β | 2016 | β |
| Direct High Affinity Interaction between AΞ²42 and GSK3Ξ± Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer's Disease? | Dunning CJ et al. | β | 2016 | β |
| Discovery of Novel Biomarkers for Alzheimer's Disease from Blood. | Long J et al. | β | 2016 | β |
| Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases. | Zheng Q et al. | β | 2016 | β |
| Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology. | Leduc V et al. | β | 2016 | β |
| Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST). | Watanabe Y et al. | β | 2016 | β |
| Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges. | Kett LR et al. | β | 2016 | β |
| Exercise, but not antioxidants, reversed ApoE4-associated motor impairments in adult GFAP-ApoE mice. | Chaudhari K et al. | β | 2016 | β |
| Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences? | Winkler EC et al. | β | 2016 | β |
| From Common to Rare Variants: The Genetic Component of Alzheimer Disease. | Nicolas G et al. | β | 2016 | β |
| Gene Therapy Strategies for Alzheimer's Disease: An Overview. | Alves S et al. | β | 2016 | β |
| Genetic variants associated with neurodegenerative Alzheimer disease in natural models. | Salazar C et al. | β | 2016 | β |
| Genomics of Alzheimer Disease: A Review. | Rosenberg RN et al. | β | 2016 | β |
| Identification and in Vivo Evaluation of Liver X Receptor Ξ²-Selective Agonists for the Potential Treatment of Alzheimer's Disease. | Stachel SJ et al. | β | 2016 | β |
| Immunotherapies in Alzheimer's disease: Too much, too little, too late or off-target? | St-Amour I et al. | β | 2016 | β |
| Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease. | Caberlotto L et al. | β | 2016 | β |
| Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. | Uchoa MF et al. | β | 2016 | β |
| Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models. | Zhao L et al. | β | 2016 | β |
| Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease. | De Luca V et al. | β | 2016 | β |
| Living long and ageing well: is epigenomics the missing link between nature and nurture? | Rea IM et al. | β | 2016 | β |
| Mitochondrial Regulatory Pathways inΒ theΒ Pathogenesis of Alzheimer's Disease. | Adiele RC et al. | β | 2016 | β |
| Molecular architecture of AΞ² fibrils grown in cerebrospinal fluid solution and in a cell culture model of AΞ² plaque formation. | Garvey M et al. | β | 2016 | β |
| Molecular genetics of early-onset Alzheimer's disease revisited. | Cacace R et al. | β | 2016 | β |
| Neprilysin Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese. | Wang HZ et al. | β | 2016 | β |
| Neuroprotective Effects Against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton. | Liebert AD et al. | β | 2016 | β |
| Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation. | Need AC et al. | β | 2016 | β |
| NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease. | Iyappan A et al. | β | 2016 | β |
| Next Generation Sequencing in Alzheimer's Disease. | Bertram L | β | 2016 | β |
| Obesity and sex interact in the regulation of Alzheimer's disease. | Moser VA et al. | β | 2016 | β |
| Palmitoylation in Alzheimer's disease and other neurodegenerative diseases. | Cho E et al. | β | 2016 | β |
| Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients. | Zamani M et al. | β | 2016 | β |
| Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases. | Convertino M et al. | β | 2016 | β |
| Phosphatidylcholine protects neurons from toxic effects of amyloid Ξ²-protein in culture. | Ko M et al. | β | 2016 | β |
| Presenilin E318G variant and Alzheimer's disease risk: the Cache County study. | Hippen AA et al. | β | 2016 | β |
| Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease. | Jakobsdottir J et al. | β | 2016 | β |
| Relationship between APOE Genotype and Structural MRI Measures throughout Adulthood in the Study of Health in Pomerania Population-Based Cohort. | Habes M et al. | β | 2016 | β |
| Repetitive mild traumatic brain injury with impact acceleration in the mouse: Multifocal axonopathy, neuroinflammation, and neurodegeneration in the visual system. | Xu L et al. | β | 2016 | β |
| Risk factors of post-operative delirium after elective vascular surgery in the elderly: A systematic review. | Raats JW et al. | β | 2016 | β |
| Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease. | Andersen OM et al. | β | 2016 | β |
| Role of APOE Ξ΅4 Allele and Incident Stroke on Cognitive Decline and Mortality. | Rajan KB et al. | β | 2016 | β |
| Role of genes GSTM1, GSTT1, and MnSOD in the development of late-onset Alzheimer disease and their relationship with APOE*4. | de MendonΓ§a E et al. | β | 2016 | β |
| Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. | Pistollato F et al. | β | 2016 | β |
| Structural variants can be more informative for disease diagnostics, prognostics and translation than current SNP mapping and exon sequencing. | Roses AD et al. | β | 2016 | β |
| Student-Athletes' Views on APOE Genotyping for Increased Risk of Poor Recovery after a Traumatic Brain Injury. | Hercher LS et al. | β | 2016 | β |
| Systems Biology of Alzheimer's Disease. Preface. | Castrillo JI et al. | β | 2016 | β |
| Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. | Ε imiΔ G et al. | β | 2016 | β |
| The effect of ApoE e4 on blood pressure in patients with and without depression. | Hestad KA et al. | β | 2016 | β |
| The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. | LΓΆwe LC et al. | β | 2016 | β |
| The effects of the apoE4 genotype on the developing mouse retina. | Maharshak I et al. | β | 2016 | β |
| The lysosomal storage disease continuum with ageing-related neurodegenerative disease. | Lloyd-Evans E et al. | β | 2016 | β |
| The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model. | Li T et al. | β | 2016 | β |
| The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases. | Walter J | β | 2016 | β |
| TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. | Yeh FL et al. | β | 2016 | β |
| TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. | Colonna M et al. | β | 2016 | β |
| UPS Activation in the Battle Against Aging and Aggregation-Related Diseases: An Extended Review. | Papaevgeniou N et al. | β | 2016 | β |
| Additional mechanisms conferring genetic susceptibility to Alzheimer's disease. | Calero M et al. | β | 2015 | β |
| Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50. | Aboud O et al. | β | 2015 | β |
| Aging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention. | Jonaitis EM et al. | β | 2015 | β |
| Alzheimer's disease. | Masters CL et al. | β | 2015 | β |
| Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease. | Barage SH et al. | β | 2015 | β |
| Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights. | Das M et al. | β | 2015 | β |
| An analytical framework in the general coalescent tree setting for analyzing polymorphisms created by two mutations. | Sargsyan O | β | 2015 | β |
| ApoE4 and AΞ² Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation. | Sen A et al. | β | 2015 | β |
| APOE Effects on Default Mode Network in Chinese Cognitive Normal Elderly: Relationship with Clinical Cognitive Performance. | Song H et al. | β | 2015 | β |
| APOE-Ι4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease. | Waring JF et al. | β | 2015 | β |
| APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice. | Zhou Y et al. | β | 2015 | β |
| APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders. | Yin Z et al. | β | 2015 | β |
| Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. | Kumar NT et al. | β | 2015 | β |
| Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). | Atagi Y et al. | β | 2015 | β |
| Apolipoprotein Ξ΅4 is associated with lower brain volume in cognitively normal Chinese but not white older adults. | Yokoyama JS et al. | β | 2015 | β |
| Association between polymorphisms of the insulin-degrading enzyme gene and late-onset Alzheimer disease. | Wang S et al. | β | 2015 | β |
| Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review. | Zhang S et al. | β | 2015 | β |
| Association of air pollution with cognitive functions and its modification by APOE gene variants in elderly women. | Schikowski T et al. | β | 2015 | β |
| Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population. | Sapkota B et al. | β | 2015 | β |
| Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population. | Wu P et al. | β | 2015 | β |
| Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-Ξ² Peptides in an In Vitro Model of the Human Blood-Brain Barrier. | Kuntz M et al. | β | 2015 | β |
| BFLCRM: A BAYESIAN FUNCTIONAL LINEAR COX REGRESSION MODEL FOR PREDICTING TIME TO CONVERSION TO ALZHEIMER'S DISEASE. | Lee E et al. | β | 2015 | β |
| Biomarkers in Sporadic and Familial Alzheimer's Disease. | Lista S et al. | β | 2015 | β |
| Computer simulation studies of AΞ²37-42 aggregation thermodynamics and kinetics in water and salt solution. | Yang YI et al. | β | 2015 | β |
| Cytokines and Postoperative Delirium in Older Patients Undergoing Major Elective Surgery. | Vasunilashorn SM et al. | β | 2015 | β |
| Does Apolipoprotein E Genotype Increase Risk of Postoperative Delirium? | Vasunilashorn S et al. | β | 2015 | β |
| Early-onset Alzheimers and cortical vision impairment in a woman with valosin-containing protein disease associated with 2 APOE Ξ΅4/APOE Ξ΅4 genotype. | Shamirian S et al. | β | 2015 | β |
| Epigenomics of Alzheimer's disease. | Bennett DA et al. | β | 2015 | β |
| Expert consensus document: Mind the gapsβadvancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions. | Carman AJ et al. | β | 2015 | β |
| Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. | Gupta VB et al. | β | 2015 | β |
| From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration. | Zhao Y et al. | β | 2015 | β |
| Fuzzy-Trace Theory and Lifespan Cognitive Development. | Brainerd CJ et al. | β | 2015 | β |
| Gangliosides: glycosphingolipids essential for normal neural development and function. | Schengrund CL | β | 2015 | β |
| Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). | Davies G et al. | β | 2015 | β |
| Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease. | Lee SL et al. | β | 2015 | β |
| High levels of homocysteine results in cerebral amyloid angiopathy in mice. | Li JG et al. | β | 2015 | β |
| HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study. | Leduc V et al. | β | 2015 | β |
| Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. | Villeneuve S et al. | β | 2015 | β |
| Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update. | Zhang ZG et al. | β | 2015 | β |
| Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. | van Dijk G et al. | β | 2015 | β |
| Lipids in Amyloid-Ξ² Processing, Aggregation, and Toxicity. | Morgado I et al. | β | 2015 | β |
| Longitudinal cognitive decline in the AIBL cohort: The role of APOE Ξ΅4 status. | Albrecht MA et al. | β | 2015 | β |
| Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease. | Steinberg S et al. | β | 2015 | β |
| Milk metabolites and neurodegeneration: Is there crosstalk? | Thakur K et al. | β | 2015 | β |
| Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal. | Sandhir R et al. | β | 2015 | β |
| Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. | Liao F et al. | β | 2015 | β |
| Myelin basic protein associates with AΞ²PP, AΞ²1-42, and amyloid plaques in cortex of Alzheimer's disease brain. | Zhan X et al. | β | 2015 | β |
| Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. | Walker L et al. | β | 2015 | β |
| No association between ApoΞ΅4 alleles, HIV infection, age, neuropsychological outcome, or death. | Becker JT et al. | β | 2015 | β |
| No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population. | Fachal L et al. | β | 2015 | β |
| Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus. | Woltjer RL et al. | β | 2015 | β |
| Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease. | van Leeuwen LA et al. | β | 2015 | β |
| Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases. | Montine TJ et al. | β | 2015 | β |
| Precocious Alterations of Brain Oscillatory Activity in Alzheimer's Disease: A Window of Opportunity for Early Diagnosis and Treatment. | Hamm V et al. | β | 2015 | β |
| Regulation of age-related macular degeneration-like pathology by complement factor H. | Toomey CB et al. | β | 2015 | β |
| Role of apolipoprotein E in neurodegenerative diseases. | Giau VV et al. | β | 2015 | β |
| Role of Apolipoprotein E in Ξ²-Amyloidogenesis: ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF AΞ² IN VITRO AND BRAIN AΞ² DEPOSITION IN VIVO. | Hori Y et al. | β | 2015 | β |
| Self-Assembling Peptides Form Immune Suppressive Amyloid Fibrils Effective in Autoimmune Encephalomyelitis. | Kurnellas MP et al. | β | 2015 | β |
| The benefit of docosahexaenoic acid for the adult brain in aging and dementia. | Salem N et al. | β | 2015 | β |
| The case for rejecting the amyloid cascade hypothesis. | Herrup K | β | 2015 | β |
| The genetic architecture of autism spectrum disorders (ASDs) and the potential importance of common regulatory genetic variants. | Saffen D | β | 2015 | β |
| The Glymphatic System: A Beginner's Guide. | Jessen NA et al. | β | 2015 | β |
| The molecular genetic architecture of attention deficit hyperactivity disorder. | Hawi Z et al. | β | 2015 | β |
| The role of APOE-Ι4 and beta amyloid in the differential rate of recovery from ECT: a review. | Sutton TA et al. | β | 2015 | β |
| The Role of PICALM in Alzheimer's Disease. | Xu W et al. | β | 2015 | β |
| The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E. | Bailey CC et al. | β | 2015 | β |
| Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-Ξ² (AΞ²) Oligomer and AΞ²PP and Protects Neurons from AΞ²-Induced Toxicity. | Hong HS et al. | β | 2015 | β |
| Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models. | Martiskainen H et al. | β | 2015 | β |
| Translational Meta-analytical Methods to Localize the Regulatory Patterns of Neurological Disorders in the Human Brain. | Sochat V et al. | β | 2015 | β |
| TREM2 in CNS homeostasis and neurodegenerative disease. | Painter MM et al. | β | 2015 | β |
| Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network. | Cao S et al. | β | 2015 | β |
| Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease. | Beck TN et al. | β | 2014 | β |
| Alzheimer's disease: Current Trends in Wales. | Abdulrahman GO et al. | β | 2014 | β |
| Alzheimer's disease: The forgetting gene. | Spinney L | β | 2014 | β |
| A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphisms. | Yi L et al. | β | 2014 | β |
| Anti-ApoE antibody given after plaque onset decreases AΞ² accumulation and improves brain function in a mouse model of AΞ² amyloidosis. | Liao F et al. | β | 2014 | β |
| APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease. | Zhou Q et al. | β | 2014 | β |
| ApoE gene and exceptional longevity: Insights from three independent cohorts. | Garatachea N et al. | β | 2014 | β |
| ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury. | Wang R et al. | β | 2014 | β |
| Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. | Dassati S et al. | β | 2014 | β |
| Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. | Ungar L et al. | β | 2014 | β |
| Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis. | Liu M et al. | β | 2014 | β |
| Apolipoprotein E receptor pathways in Alzheimer disease. | Schmidt V et al. | β | 2014 | β |
| Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. | Huang Y et al. | β | 2014 | β |
| Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy. | Pievani M et al. | β | 2014 | β |
| Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease. | Landry GJ et al. | β | 2014 | β |
| cDNA microarray and bioinformatic analysis for the identification of key genes in Alzheimer's disease. | Gu C et al. | β | 2014 | β |
| Ceramides and sphingomyelinases in senile plaques. | Panchal M et al. | β | 2014 | β |
| Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. | Mielke MM et al. | β | 2014 | β |
| Clinical genetics of Alzheimer's disease. | Zou Z et al. | β | 2014 | β |
| Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. | Dugger BN et al. | β | 2014 | β |
| Coding variants in TREM2 increase risk for Alzheimer's disease. | Jin SC et al. | β | 2014 | β |
| Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view. | Walhovd KB et al. | β | 2014 | β |
| Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists. | Lange M et al. | β | 2014 | β |
| Common GSAP promoter variant contributes to Alzheimer's disease liability. | Zhu M et al. | β | 2014 | β |
| Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. | Huang HJ et al. | β | 2014 | β |
| Diabetes and neurodegeneration in the brain. | Toth C | β | 2014 | β |
| Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer's disease. | Alzate O et al. | β | 2014 | β |
| Effects of normal aging and SCN1A risk-gene expression on brain metabolites: evidence for an association between SCN1A and myo-inositol. | Tunc-Skarka N et al. | β | 2014 | β |
| Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids. | Yang M et al. | β | 2014 | β |
| Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population. | Omoumi A et al. | β | 2014 | β |
| Exercise, APOE genotype, and the evolution of the human lifespan. | Raichlen DA et al. | β | 2014 | β |
| Frequency of the apolipoprotein E Ξ΅4 allele in a memory clinic cohort in Beijing: a naturalistic descriptive study. | Wang X et al. | β | 2014 | β |
| Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes. | Gharesouran J et al. | β | 2014 | β |
| Genetics in degenerative dementia: current status and applicability. | Bruni AC et al. | β | 2014 | β |
| Genetics of Alzheimer's disease. | Chouraki V et al. | β | 2014 | β |
| Genetics of cognition in epilepsy. | Busch RM et al. | β | 2014 | β |
| Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement Study. | Zhang C et al. | β | 2014 | β |
| Genomic aspects of sporadic neurodegenerative diseases. | Mitsui J et al. | β | 2014 | β |
| Haptoglobin interacts with apolipoprotein E and beta-amyloid and influences their crosstalk. | Spagnuolo MS et al. | β | 2014 | β |
| Human APOE4 increases microglia reactivity at AΞ² plaques in a mouse model of AΞ² deposition. | Rodriguez GA et al. | β | 2014 | β |
| Human APOE genotype affects intraneuronal AΞ²1-42 accumulation in a lentiviral gene transfer model. | Zhao W et al. | β | 2014 | β |
| Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer's disease. | Westman G et al. | β | 2014 | β |
| Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. | Osorio RS et al. | β | 2014 | β |
| Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. | RΓos JA et al. | β | 2014 | β |
| LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice. | Stukas S et al. | β | 2014 | β |
| Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology. | Wong BX et al. | β | 2014 | β |
| MicroRNAs: a connection between cholesterol metabolism and neurodegeneration. | Goedeke L et al. | β | 2014 | β |
| Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. | Vega JN et al. | β | 2014 | β |
| Modeling cerebrovascular pathophysiology in amyloid-Ξ² metabolism using neural-crest-derived smooth muscle cells. | Cheung C et al. | β | 2014 | β |
| Myelin injury and degraded myelin vesicles in Alzheimer's disease. | Zhan X et al. | β | 2014 | β |
| Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. | PΓ©rez-Palma E et al. | β | 2014 | β |
| Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020. | Hampel H et al. | β | 2014 | β |
| Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview. | Turturici G et al. | β | 2014 | β |
| [Prevalence of Variants in the Apolipoprotein E (APOE) Gene in a General Population of Adults from an Urban Area of Medellin (Antioquia)]. | Arango Viana JC et al. | β | 2014 | β |
| Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2. | Vandal M et al. | β | 2014 | β |
| Related genes and potential biomarkers for early diagnosis of Alzheimer's disease: a preliminary study based on DNA microarray. | Lin H et al. | β | 2014 | β |
| Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway. | Zhao J et al. | β | 2014 | β |
| Soluble apoE/AΞ² complex: mechanism and therapeutic target for APOE4-induced AD risk. | Tai LM et al. | β | 2014 | β |
| Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside. | Fan X et al. | β | 2014 | β |
| The binding of apolipoprotein E to oligomers and fibrils of amyloid-Ξ² alters the kinetics of amyloid aggregation. | Garai K et al. | β | 2014 | β |
| The involvement of lipids in Alzheimer's disease. | Lim WL et al. | β | 2014 | β |
| The multiscale backbone of the human phenotype network based on biological pathways. | Darabos C et al. | β | 2014 | β |
| The potential applications of Apolipoprotein E in personalized medicine. | Villeneuve S et al. | β | 2014 | β |
| The role of apolipoprotein E in neurodegeneration and cardiovascular disease. | Lopez MF et al. | β | 2014 | β |
| Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease. | BabiΔ M et al. | β | 2014 | β |
| Whole-genome analyses of whole-brain data: working within an expanded search space. | Medland SE et al. | β | 2014 | β |
| Women with the Alzheimer's risk marker ApoE4 lose AΞ²-specific CD4βΊ T cells 10-20 years before men. | Begum AN et al. | β | 2014 | β |
| Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: a mini-review. | Lee J et al. | β | 2014 | β |
| Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila. | Konsolaki M | β | 2013 | β |
| Modification of the relationship of the apolipoprotein E Ξ΅4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. | Lim AS et al. | β | 2013 | β |
| Novel natural structure corrector of ApoE4 for checking Alzheimer's disease: benefits from high throughput screening and molecular dynamics simulations. | Goyal M et al. | β | 2013 | β |
| Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem. | Gendreau KL et al. | β | 2013 | β |
| The absence of myelin basic protein promotes neuroinflammation and reduces amyloid Ξ²-protein accumulation in Tg-5xFAD mice. | Ou-Yang MH et al. | β | 2013 | β |
| The PREVENT research programme--a novel research programme to identify and manage midlife risk for dementia: the conceptual framework. | Ritchie CW et al. | β | 2013 | β |